"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. . "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. nedocromil. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h17no7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0b535e0bn0, chemically known as 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4h-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid but generally known as nedocromil, which bears us nih compound identifier 50294. european medicines agency schedules nedocromil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09179mig. the term nedocromil is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules nedocromil in its anatomical therapeutic chemical (atc) classification. nedocromil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nedocromil under hs 29349990 and sitc 51579. as of q4 2014, nedocromil remains the us fda preferred term for this commodity. nedocromil bears us nlm identifiers umls id c0068483 and nci concept code c66225. smiles: o1c2c(c3n(cc)c(cc(=o)c3cc2c(=o)cc1c(=o)o)c(=o)o)ccc.. "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. efletirizine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b6c301298g. european medicines agency schedules efletirizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06467mig. efletirizine generally arises in the molecular formula c21h24f2n2o3. the term efletirizine is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35.) efletirizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule efletirizine under hs 29335995 and sitc 51576. as of q4 2014, efletirizine remains the us fda preferred term for this commodity. efletirizine bears us nlm identifiers umls id c0893504 and nci concept code c73048. smiles: fc1ccc(c(n2ccn(cc2)ccocc(=o)o)c2ccc(f)cc2)cc1.. "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. mepyramine or pyrilamine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h23n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hpe317o9tl, chemically known as 1,2-ethanediamine, n-((4-methoxyphenyl)methyl)-n,n-dimethyl-n-2-pyridinyl- (9ci) but generally known as mepyramine, which bears us nih compound identifier 4992. european medicines agency schedules mepyramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08762mig. the term mepyramine is an international non-proprietary name. world health organization schedules mepyramine in its anatomical therapeutic chemical (atc) classification. mepyramine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. mepyramine or pyrilamine bears us nlm identifiers umls id c0034282 and nci concept code c76676. smiles: cn(c)ccn(cc1=cc=c(c=c1)oc)c2=cc=cc=n2.. "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. setastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c22h28clno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6g3ocf528j, chemically known as 1h-azepine, 1-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)hexahydro- but generally known as setastine, which bears us nih compound identifier 43082. european medicines agency schedules setastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10500mig. the term setastine is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). setastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule setastine under hs 29339930 and sitc 51577. as of q4 2014, setastine remains the us fda preferred term for this commodity. setastine bears us nlm identifiers umls id c0074409 and nci concept code c73056. smiles: clc1ccc(c(occn2cccccc2)(c2ccccc2)c)cc1.. "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. efletirizine dihydrochloride. this classification denotes a histamine-1 receptor antagonist c21h24f2n2o3.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jq7zt5mra0, chemically known as (2-(4-bis(p-fluorophenyl)methyl)-1-piperazinyl)ethoxy)acetic acid, dihydrochloride, but more generally known as efletirizine dihydrochloride, which bears us nih compound identifier 156659. most nations, for tariff and trade purposes, schedule efletirizine dihydrochloride under hs 29335995 and sitc 51576. as of q4 2014, efletirizine dihydrochloride remains us fdas preferred term for this commodity. efletirizine dihydrochloride bears us nlm identifiers umls id c2348383 and nci concept code c72751. smiles: c1cc(ccc1c(c2ccc(cc2)f)n3ccn(cc3)ccocc(=o)o)f.cl.cl.. "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. mepyramine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular structure c17h23n3o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 5t3r4p0i14 chemically known as 1,2-ethanediamine, n1-((4-methoxyphenyl)methyl)-n2,n2-dimethyl-n1-2-pyridinyl-, hydrochloride (1:1), but more commonly known as mepyramine hydrochloride, which bears us nih compound identifier 80139. european medicines agency schedules mepyramine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14515mig. most nations, for tariff and trade purposes, schedule mepyramine hydrochloride under hs 29333999. smiles: cn(c)ccn(cc1ccc(cc1)oc)c2ccccn2.cl.. "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. mepyramine maleate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h23n3o.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r35d29l3za, chemically known as n-(p-methoxybenzyl)-n, n-dimethyl-n-.alpha.-pyridylethylenediamine maleate but more generally known as mepyramine maleate, which bears us nih compound identifier 5284451. european medicines agency schedules mepyramine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14516mig. most nations, for tariff and trade purposes, schedule mepyramine maleate under hs 29333999. smiles: cn(c)ccn(cc1ccc(cc1)oc)c2ccccn2.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. mepyramine tannate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c76h52o46.c17h23n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a9310lw34b. european medicines agency schedules mepyramine tannate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03164mig. most nations, for tariff and trade purposes, schedule mepyramine tannate under hs 29333999. smiles:.. "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. nedocromil calcium. this classification denotes a histamine-1 receptor antagonist c19h15no7.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0983w479hh, chemically known as calcium 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4h-pyrano(3,2-g)quinoline-2,8-dicarboxylate (1:1), but more generally known as nedocromil calcium, which bears us nih compound identifier 68731. european medicines agency schedules nedocromil calcium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14633mig. most nations, for tariff and trade purposes, schedule nedocromil calcium under hs 29349990 and sitc 51579. as of q4 2014, nedocromil calcium remains us fdas preferred term for this commodity. nedocromil calcium bears us nlm identifiers umls id c0282470 and nci concept code c82647. smiles: cccc1c2c(cc3c1oc(cc3=o)c(=o)[o-])c(=o)cc(n2cc)c(=o)[o-].[ca+2].. "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. nedocromil sodium. this classification denotes a nonsteroidal antiinflammatory drug with the molecular formula c19h15no7.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier et8if4ks1t, chemically known as 4h-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, disodium salt but more generally known as nedocromil sodium, which bears us nih compound identifier 50295. european medicines agency schedules nedocromil sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14634mig. most nations, for tariff and trade purposes, schedule nedocromil sodium under hs 29349990 and sitc 51579. as of q4 2014, nedocromil sodium remains us fdas preferred term for this commodity. nedocromil sodium bears us nlm identifiers umls id c0886658 and nci concept code c47635. smiles: cccc1c2c(cc3c1oc(cc3=o)c(=o)[o-])c(=o)cc(n2cc)c(=o)[o-].[na+].[na+].. "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. setastine hydrochloride. this classification denotes a histamine-1 receptor antagonist c22h28clno.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t2mb6p84on, chemically known as setastine hydrochloride, (+/-)-, but more generally known as setastine hydrochloride, which bears us nih compound identifier 43081. european medicines agency schedules setastine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15235mig. most nations, for tariff and trade purposes, schedule setastine hydrochloride under hs 29339930 and sitc 51577. as of q4 2014, setastine hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c1ccccc1)(c2ccc(cc2)cl)occn3cccccc3.cl.. "
"antihistamine or h1 blocker 4-quinolones and acetates and aminopyridines and azepines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on 4-quinolones, acetates, aminopyridines, or azepines. isospaglumic acid. it is a broad spectrum antiallergic and treats the allergic eye diseases without corticotherapy risks.. "
"antihistamine or h1 blocker benzhydryl compounds. antihistamine or h1 blocker drugs made from compounds which contain the methyl radical substituted with two benzene rings. permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.. . "
"antihistamine or h1 blocker benzhydryl compounds. antihistamine or h1 blocker drugs made from compounds which contain the methyl radical substituted with two benzene rings. permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.. meclizine or meclozine. this classification denotes a histamine-1 receptor antagonist and antiemetic agent with the molecular formula c25h27cln2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3l5tq84570, chemically known as piperazine, 1- (p-chloro-.alpha.-phenylbenzyl)-4-(m-methylbenzyl)-, dihydrochloride but generally known as meclizine, which bears us nih compound identifier 4034. european medicines agency schedules meclozine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08685mig. the term meclizine is an international non-proprietary name. world health organization schedules meclizine in its anatomical therapeutic chemical (atc) classification. meclizine or meclozine bears us nlm identifiers umls id c0025039 and nci concept code c61610. smiles: cc1=cc(=cc=c1)cn2ccn(cc2)c(c3=cc=cc=c3)c4=cc=c(c=c4)cl.. "
"antihistamine or h1 blocker benzhydryl compounds. antihistamine or h1 blocker drugs made from compounds which contain the methyl radical substituted with two benzene rings. permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.. phenyltoloxamine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h21no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k65lb6598j, chemically known as n,n-dimethyl-2-(alpha-phenyl-o-tolyloxy)ethylamine but generally known as phenyltoloxamine, which bears us nih compound identifier 7077. european medicines agency schedules phenyltoloxamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09791mig. the term phenyltoloxamine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). phenyltoloxamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule phenyltoloxamine under hs 29221980 and sitc 51461. as of q4 2014, phenyltoloxamine remains the us fda preferred term for this commodity. phenyltoloxamine bears us nlm identifiers umls id c0070709 and nci concept code c47669. smiles: o(c1c(cc2ccccc2)cccc1)ccn(c)c.. "
"antihistamine or h1 blocker benzhydryl compounds. antihistamine or h1 blocker drugs made from compounds which contain the methyl radical substituted with two benzene rings. permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.. quifenadine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c20h23no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w9a18rj49b, chemically known as 3-quinuclidinemethanol, alpha,alpha-diphenyl- but generally known as quifenadine, which bears us nih compound identifier 65600. european medicines agency schedules quifenadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10193mig. the term quifenadine is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). quifenadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule quifenadine under hs 29333999 and sitc 51574. as of q4 2014, quifenadine remains the us fda preferred term for this commodity. quifenadine bears us nlm identifiers umls id c0243449 and nci concept code c81147. smiles: oc(c1c2ccn(c1)cc2)(c1ccccc1)c1ccccc1.. "
"antihistamine or h1 blocker benzhydryl compounds. antihistamine or h1 blocker drugs made from compounds which contain the methyl radical substituted with two benzene rings. permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.. phenyltoloxamine citrate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h21no.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8ue48mjh8m, chemically known as n,n-dimethyl-2-(alpha-phenyl-o-toloxy)ethylamine dihydrogen citrate but more generally known as phenyltoloxamine citrate, which bears us nih compound identifier 14440. european medicines agency schedules phenyltoloxamine citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03784mig. most nations, for tariff and trade purposes, schedule phenyltoloxamine citrate under hs 29221980 and sitc 51461. as of q4 2014, phenyltoloxamine citrate remains us fdas preferred term for this commodity. phenyltoloxamine citrate bears us nlm identifiers umls id c0724662 and nci concept code c82275. smiles: cn(c)ccoc1ccccc1cc2ccccc2.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"antihistamine or h1 blocker benzhydryl compounds. antihistamine or h1 blocker drugs made from compounds which contain the methyl radical substituted with two benzene rings. permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.. phenyltoloxamine dihydrogen citrate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h21no.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8ue48mjh8m, chemically known as n,n-dimethyl-2-(alpha-phenyl-o-toloxy)ethylamine dihydrogen citrate but more generally known as phenyltoloxamine citrate, which bears us nih compound identifier 14440. european medicines agency schedules phenyltoloxamine citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03784mig. most nations, for tariff and trade purposes, schedule phenyltoloxamine dihydrogen citrate under hs 29221980. smiles: cn(c)ccoc1ccccc1cc2ccccc2.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"antihistamine or h1 blocker benzhydryl compounds. antihistamine or h1 blocker drugs made from compounds which contain the methyl radical substituted with two benzene rings. permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.. phenyltoloxamine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h21no.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 56o4h6zt2k, chemically known as n,n-dimethyl-2-(alpha-phenyl-o-toloxy)-ethylamine hydrochloride but more generally known as phenyltoloxamine hydrochloride, which bears us nih compound identifier 22528. most nations, for tariff and trade purposes, schedule phenyltoloxamine hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, phenyltoloxamine hydrochloride remains us fdas preferred term for this commodity. phenyltoloxamine hydrochloride bears us nlm identifiers umls id c0770856 and nci concept code c97702. smiles: cn(c)ccoc1ccccc1cc2ccccc2.cl.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. . "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. astemizole. this classification denotes a histamine-1 receptor antagonist with the molecular formula c28h31fn4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7hu6337315, chemically known as 1h-benzimidazol-2-amine, 1-((4-fluorophenyl)methyl)-n-(1-(2-(4-methoxyphenyl)ethyl)-4-piperidinyl)- but generally known as astemizole, which bears us nih compound identifier 2247. european medicines agency schedules astemizole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05586mig. the term astemizole is an international non-proprietary name. world health organization schedules astemizole in its anatomical therapeutic chemical (atc) classification. astemizole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule astemizole under hs 29333999 and sitc 51574. as of q4 2014, astemizole remains the us fda preferred term for this commodity. astemizole bears us nlm identifiers umls id c0699606 and nci concept code c28834. smiles: fc1ccc(cn2c(nc3ccn(cc3)ccc3ccc(oc)cc3)nc3c2cccc3)cc1.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. bilastine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pa1123n395. european medicines agency schedules bilastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub37845. bilastine generally arises in the molecular formula c28h37n3o3. the term bilastine is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44.) most nations schedule bilastine under hs 29333999 and sitc 51574. as of q4 2014, bilastine remains the us fda preferred term for this commodity. bilastine bears us nlm identifiers umls id c1101148 and nci concept code c73045. smiles: o(ccn1c(nc2c1cccc2)c1ccn(cc1)ccc1ccc(c(c)(c)c(=o)o)cc1)cc.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. clemizole. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h20cln3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t97cb3796l, chemically known as 1h-benzimidazole, 1-((4-chlorophenyl)methyl)-2-(1-pyrrolidinylmethyl)- but generally known as clemizole, which bears us nih compound identifier 2782. european medicines agency schedules clemizole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06650mig. the term clemizole is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). clemizole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clemizole under hs 29339990 and sitc 51577. as of q4 2014, clemizole remains the us fda preferred term for this commodity. clemizole bears us nlm identifiers umls id c0008931 and nci concept code c81139. smiles: clc1ccc(cn2c(nc3c2cccc3)cn2cccc2)cc1.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. emedastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h26n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9j1h7y9ojv, chemically known as 1-methyl-4-(1-(2-ethoxyethyl)-1h-benzimidazo)-2-yl)(1,4)diazepane but generally known as emedastine, which bears us nih compound identifier 3219. european medicines agency schedules emedastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06503mig. the term emedastine is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules emedastine in its anatomical therapeutic chemical (atc) classification. emedastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule emedastine under hs 29339940 and sitc 51577. as of q4 2014, emedastine remains the us fda preferred term for this commodity. emedastine bears us nlm identifiers umls id c0064263 and nci concept code c61743. smiles: o(ccn1c(n2cccn(cc2)c)nc2c1cccc2)cc.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. mapinastine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 62ln840sfz. european medicines agency schedules mapinastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08646mig. mapinastine generally arises in the molecular formula c23h34n6o. the term mapinastine is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35.) mapinastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mapinastine under hs 29335995 and sitc 51576. as of q4 2014, mapinastine remains the us fda preferred term for this commodity. mapinastine bears us nlm identifiers umls id c1881605 and nci concept code c66055. smiles: o(ccn1c(nc2c1cccc2)cn1ccn(cc1)ccccn1nccc1)cc.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. mizolastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c24h25fn6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 244o1f90na, chemically known as 4(1h)-pyrimidinone, 2-((1-(1-((4-fluorophenyl)methyl)-1h-benzimidazol-2-yl)-4-piperidinyl)methylamino)- but generally known as mizolastine, which bears us nih compound identifier 65906. european medicines agency schedules mizolastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09018mig. the term mizolastine is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules mizolastine in its anatomical therapeutic chemical (atc) classification. most nations schedule mizolastine under hs 29335995 and sitc 51576. as of q4 2014, mizolastine remains the us fda preferred term for this commodity. mizolastine bears us nlm identifiers umls id c0171302 and nci concept code c66171. smiles: fc1ccc(cn2c(n3ccc(n(c)c4[nh]c(=o)ccn4)cc3)nc3c2cccc3)cc1.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. clemizole hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h20cln3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 85w6i13d8m, chemically known as benzimidazole, 1-(p-chlorobenzyl)-2-(1-pyrrolidinylmethyl)-, monohydrochloride but more generally known as clemizole hydrochloride, which bears us nih compound identifier 14412. european medicines agency schedules clemizole hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01336mig. most nations, for tariff and trade purposes, schedule clemizole hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, clemizole hydrochloride remains us fdas preferred term for this commodity. clemizole hydrochloride bears us nlm identifiers umls id c2825478 and nci concept code c81152. smiles: c1ccc2c(c1)nc(n2cc3ccc(cc3)cl)cn4cccc4.cl.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. clemizole sulfate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h20cln3.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5aa1g805h0, chemically known as 1h-benzimidazole, 1-((4-chlorophenyl)methyl)-2-(1-pyrrolidinylmethyl)- but more generally known as clemizole sulfate, which bears us nih compound identifier 2782. most nations, for tariff and trade purposes, schedule clemizole sulfate under hs 29339990 and sitc 51577. as of q4 2014, clemizole sulfate remains us fdas preferred term for this commodity. clemizole sulfate bears us nlm identifiers umls id c3273572 and nci concept code c97694. smiles: c1ccc2c(c1)nc(n2cc3ccc(cc3)cl)cn4cccc4.os(=o)(=o)o.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. clemizole sulphate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h20cln3.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5aa1g805h0, chemically known as 1h-benzimidazole, 1-((4-chlorophenyl)methyl)-2-(1-pyrrolidinylmethyl)- but more generally known as clemizole sulfate, which bears us nih compound identifier 2782. most nations, for tariff and trade purposes, schedule clemizole sulphate under hs 29339990. smiles: c1ccc2c(c1)nc(n2cc3ccc(cc3)cl)cn4cccc4.os(=o)(=o)o.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. clemizole undecylate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h20cln3.c11h22o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6k5xap3a37, chemically known as 1h-benzimidazole, 1-((4-chlorophenyl)methyl)-2-(1-pyrrolidinylmethyl)-, monoundecanoate, but more generally known as clemizole undecylate, which bears us nih compound identifier 656650. european medicines agency schedules clemizole undecylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06650mig. most nations, for tariff purposes, schedule clemizole undecylate under hs 29339990. clemizole undecylate bears us nlm identifiers umls id c3273573 and nci concept code c97695. smiles: ccccccccccc(=o)o.c1ccc2c(c1)nc(n2cc3ccc(cc3)cl)cn4cccc4.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. emedastine difumarate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h26n4o.2c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 42mb94qosm, chemically known as 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1h-1,4-diazepin-1-yl)benzimidazole fumarate (1:2), but more generally known as emedastine difumarate, which bears us nih compound identifier 5282485. european medicines agency schedules emedastine difumarate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06503mig. most nations, for tariff purposes, schedule emedastine difumarate under hs 29339940. as of q4 2014, emedastine difumarate remains us fdas preferred term for this commodity. emedastine difumarate bears us nlm identifiers umls id c0724578 and nci concept code c61744. smiles: ccoccn1c(nc2c1cccc2)n3ccn(ccc3)c.c(=c/c(=o)o)\\c(=o)o.c(=c/c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker benzimidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. emedastine fumarate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h26n4o.2c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 42mb94qosm. european medicines agency schedules emedastine fumarate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01874mig. most nations, for tariff and trade purposes, schedule emedastine fumarate under hs 29339940 and sitc 51577. smiles: ccoccn1c(nc2c1cccc2)n3ccn(ccc3)c.c(=c/c(=o)o)\\c(=o)o.c(=c/c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker benzopyrans. antihistamine or h1 blocker drugs made from compounds with a core of fused benzo-pyran rings.. . "
"antihistamine or h1 blocker benzopyrans. antihistamine or h1 blocker drugs made from compounds with a core of fused benzo-pyran rings.. cromoglicic acid or cromolyn. this classification denotes a mast cell stabilizer with the molecular formula c23h16o11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y0tk0fs77w, chemically known as 5,5-(2-hydroxytrimethylenedioxy)bis(4-oxochromene-2-carboxylic acid) but generally known as cromoglicic acid, which bears us nih compound identifier 27686. european medicines agency schedules cromoglicic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06825mig. the term cromoglicic acid is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules cromoglicic acid in its anatomical therapeutic chemical (atc) classification. cromoglicic acid or cromolyn bears us nlm identifiers umls id c0086073 and nci concept code c61691. smiles: o(cc(o)coc1c2c(oc(cc2=o)c(=o)o)ccc1)c1c2c(oc(cc2=o)c(=o)o)ccc1.. "
"antihistamine or h1 blocker benzopyrans. antihistamine or h1 blocker drugs made from compounds with a core of fused benzo-pyran rings.. probicromil calcium. this classification denotes a mast cell stabilizer with the molecular formula c17h10o8.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0u434950bu, chemically known as 4,6-dioxo-10-propyl-4h,6h-benzo(1,2-b:5,4-b)dipyran-2,8-dicarbonsaeure but generally known as probicromil calcium, which bears us nih compound identifier 71950. as of q4 2014, probicromil calcium remains the us fda preferred term for this commodity. probicromil calcium bears us nlm identifiers umls id c1882465 and nci concept code c66469. smiles: cccc1=c2c(=cc3=c1oc(=cc3=o)c(=o)[o-])c(=o)c=c(o2)c(=o)[o-].[ca+2].. "
"antihistamine or h1 blocker benzopyrans. antihistamine or h1 blocker drugs made from compounds with a core of fused benzo-pyran rings.. rizaben. an anti-allergy agent.. "
"antihistamine or h1 blocker butyrophenones. antihistamine or h1 blocker drugs made from compounds containing phenyl-1-butanone.. . "
"antihistamine or h1 blocker butyrophenones. antihistamine or h1 blocker drugs made from compounds containing phenyl-1-butanone.. carebastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c32h37no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 75dln707do, chemically known as benzeneacetic acid, 4-(4-(4-(diphenylmethoxy)-1-piperidinyl)-1-oxobutyl)-alpha,alpha-dimethyl- but generally known as carebastine, which bears us nih compound identifier 65820. european medicines agency schedules carebastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06623mig. the term carebastine is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). carebastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carebastine under hs 29333999 and sitc 51574. as of q4 2014, carebastine remains the us fda preferred term for this commodity. carebastine bears us nlm identifiers umls id c0209013 and nci concept code c77432. smiles: o(c1ccn(cc1)cccc(=o)c1ccc(c(c)(c)c(=o)o)cc1)c(c1ccccc1)c1ccccc1.. "
"antihistamine or h1 blocker butyrophenones. antihistamine or h1 blocker drugs made from compounds containing phenyl-1-butanone.. ebastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c32h39no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tqd7q784p1, chemically known as 1-butanone, 1-(4-(1,1-dimethylethyl)phenyl)-4-(4-(diphenylmethoxy)-1-piperidinyl)- but generally known as ebastine, which bears us nih compound identifier 3191. european medicines agency schedules ebastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06435mig. the term ebastine is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules ebastine in its anatomical therapeutic chemical (atc) classification. ebastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ebastine under hs 29333999 and sitc 51574. as of q4 2014, ebastine remains the us fda preferred term for this commodity. ebastine bears us nlm identifiers umls id c0058895 and nci concept code c77437. smiles: o(c1ccn(cc1)cccc(=o)c1ccc(c(c)(c)c)cc1)c(c1ccccc1)c1ccccc1.. "
"antihistamine or h1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates. this classification denotes antihistamine or h1 blocker drugs made from or based in part on cyclic s-oxides, dibenzazepines, dibenzoxepins, or glyoxylates. . "
"antihistamine or h1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates. this classification denotes antihistamine or h1 blocker drugs made from or based in part on cyclic s-oxides, dibenzazepines, dibenzoxepins, or glyoxylates. oxomemazine. this classification denotes an antimuscarinic agent with the molecular formula c18h22n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 305mb38v1c, chemically known as 10h-phenothiazine-10-propanamine, n,n,beta-trimethyl- but generally known as oxomemazine, which bears us nih compound identifier 5574. european medicines agency schedules oxomemazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09549mig. the term oxomemazine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules oxomemazine in its anatomical therapeutic chemical (atc) classification. oxomemazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxomemazine under hs 29343090 and sitc 51578. as of q4 2014, oxomemazine remains the us fda preferred term for this commodity. oxomemazine bears us nlm identifiers umls id c0768401 and nci concept code c73008. smiles: s1c2c(n(cc(cn(c)c)c)c3c1cccc3)cccc2.. "
"antihistamine or h1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates. this classification denotes antihistamine or h1 blocker drugs made from or based in part on cyclic s-oxides, dibenzazepines, dibenzoxepins, or glyoxylates. epinastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h15n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q13wx941ef, chemically known as 3-amino-9,13b-dihydro-1h-dibenz(c,f)imidazo(1,5-a)azepine but generally known as epinastine, which bears us nih compound identifier 3241. european medicines agency schedules epinastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06567mig. the term epinastine is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules epinastine in its anatomical therapeutic chemical (atc) classification. epinastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule epinastine under hs 29339930 and sitc 51577. as of q4 2014, epinastine remains the us fda preferred term for this commodity. epinastine bears us nlm identifiers umls id c0078442 and nci concept code c65515. smiles: n12c(c3c(cc4c1cccc4)cccc3)cn=c2n.. "
"antihistamine or h1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates. this classification denotes antihistamine or h1 blocker drugs made from or based in part on cyclic s-oxides, dibenzazepines, dibenzoxepins, or glyoxylates. olopatadine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h23no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d27v6190pm, chemically known as 11-((z)-3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid but generally known as olopatadine, which bears us nih compound identifier 5281071. european medicines agency schedules olopatadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09431mig. the term olopatadine is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules olopatadine in its anatomical therapeutic chemical (atc) classification. olopatadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule olopatadine under hs 29329985 and sitc 51569. as of q4 2014, olopatadine remains the us fda preferred term for this commodity. olopatadine bears us nlm identifiers umls id c0527189 and nci concept code c61866. smiles: o1c2c(/c(=c\\ccn(c)c)c3c(c1)cccc3)cc(cc2)cc(=o)o.. "
"antihistamine or h1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates. this classification denotes antihistamine or h1 blocker drugs made from or based in part on cyclic s-oxides, dibenzazepines, dibenzoxepins, or glyoxylates. lodoxamide. this classification denotes a mast cell stabilizer with the molecular formula c11h6cln3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier spu695od73, chemically known as n,n-(2-chlor-5-cyan-3-phenylen)dioxamsaeure but generally known as lodoxamide, which bears us nih compound identifier 44564. european medicines agency schedules lodoxamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08553mig. the term lodoxamide is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules lodoxamide in its anatomical therapeutic chemical (atc) classification. lodoxamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lodoxamide under hs 29269095 and sitc 51484. as of q4 2014, lodoxamide remains the us fda preferred term for this commodity. lodoxamide bears us nlm identifiers umls id c0126120 and nci concept code c61813. smiles: c1=c(c=c(c(=c1nc(=o)c(=o)o)cl)nc(=o)c(=o)o)c#n.. "
"antihistamine or h1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates. this classification denotes antihistamine or h1 blocker drugs made from or based in part on cyclic s-oxides, dibenzazepines, dibenzoxepins, or glyoxylates. epinastine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h15n3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gfm415s5xl, chemically known as 9,13b-dihydro-1h-dibenz(c,f)imidazo(1,5-a)azepin-3-amine hydrochloride but more generally known as epinastine hydrochloride, which bears us nih compound identifier 157313. european medicines agency schedules epinastine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01910mig. most nations, for tariff and trade purposes, schedule epinastine hydrochloride under hs 29339930 and sitc 51577. as of q4 2014, epinastine hydrochloride remains us fdas preferred term for this commodity. epinastine hydrochloride bears us nlm identifiers umls id c1321612 and nci concept code c47512. smiles: c1ccc2c(c1)cc3ccccc3n4c2cn=c4n.cl.. "
"antihistamine or h1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates. this classification denotes antihistamine or h1 blocker drugs made from or based in part on cyclic s-oxides, dibenzazepines, dibenzoxepins, or glyoxylates. lodoxamide ethyl. this classification denotes a mast cell stabilizer with the molecular formula c15h14cln3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tqy1b8145b, chemically known as acetic acid, 2,2-((2-chloro-5-cyano-1,3-phenylene)diimino)-, bis 2-oxo-, diethyl ester, but more generally known as lodoxamide ethyl, which bears us nih compound identifier 40915. european medicines agency schedules lodoxamide ethyl or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08553mig. most nations, for tariff purposes, schedule lodoxamide ethyl under hs 29269095. smiles: ccoc(=o)c(=o)nc1cc(cc(c1cl)nc(=o)c(=o)occ)c#n.. "
"antihistamine or h1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates. this classification denotes antihistamine or h1 blocker drugs made from or based in part on cyclic s-oxides, dibenzazepines, dibenzoxepins, or glyoxylates. lodoxamide tromethamine. this classification denotes a mast cell stabilizer, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 50lv9a548l. european medicines agency schedules lodoxamide trometamol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02964mig. lodoxamide tromethamine generally arises in the molecular formula c11h6cln3o6.2c4h11no3. the term lodoxamide tromethamine is a united states adopted name designation. most nations, for tariff and trade purposes, schedule lodoxamide tromethamine under hs 29269095 and sitc 51484. as of q4 2014, lodoxamide tromethamine remains us fdas preferred term for this commodity. lodoxamide tromethamine bears us nlm identifiers umls id c0065148 and nci concept code c29160. smiles: c1c(cc(c(c1nc(=o)c(=o)o)cl)nc(=o)c(=o)o)c#n.c(c(co)(co)n)o.c(c(co)(co)n)o.. "
"antihistamine or h1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates. this classification denotes antihistamine or h1 blocker drugs made from or based in part on cyclic s-oxides, dibenzazepines, dibenzoxepins, or glyoxylates. olopatadine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h23no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2xg66w44kf, chemically known as 11-((z)-3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid but more generally known as olopatadine hydrochloride, which bears us nih compound identifier 5281071. european medicines agency schedules olopatadine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03509mig. most nations, for tariff and trade purposes, schedule olopatadine hydrochloride under hs 29329985 and sitc 51569. as of q4 2014, olopatadine hydrochloride remains us fdas preferred term for this commodity. olopatadine hydrochloride bears us nlm identifiers umls id c0771892 and nci concept code c61867. smiles: cn(c)cc/c=c\\1/c2ccccc2coc3c1cc(cc3)cc(=o)o.cl.. "
"antihistamine or h1 blocker cyclic s-oxides and dibenzazepines and dibenzoxepins and glyoxylates. this classification denotes antihistamine or h1 blocker drugs made from or based in part on cyclic s-oxides, dibenzazepines, dibenzoxepins, or glyoxylates. oxomemazine hydrochloride. this classification denotes an antimuscarinic agent c18h22n2o2s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6bok44g9k6, chemically known as phenothiazine, 10-(3-(dimethylamino)-2-methylpropyl)-, 5,5-dioxide, monohydrochloride, but more generally known as oxomemazine hydrochloride, which bears us nih compound identifier 3083870. european medicines agency schedules oxomemazine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21934. most nations, for tariff and trade purposes, schedule oxomemazine hydrochloride under hs 29343090 and sitc 51578. as of q4 2014, oxomemazine hydrochloride remains us fdas preferred term for this commodity. smiles: cc(cn1c2ccccc2s(=o)(=o)c3c1cccc3)cn(c)c.cl.. "
"antihistamine or h1 blocker dibenzocycloheptenes. antihistamine or h1 blocker drugs made from a family of tricyclic hydrocarbons.. . "
"antihistamine or h1 blocker dibenzocycloheptenes. antihistamine or h1 blocker drugs made from a family of tricyclic hydrocarbons.. azatadine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c20h22n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 94z39nid6c, chemically known as 6,11-dihydro-11-(1-methyl-4-piperidylidene)-5h-benzo(5,6)cyclohepta(1,2-b)pyridine but generally known as azatadine, which bears us nih compound identifier 19861. azatadine most often comes in base, dimaleate, and maleate forms. european medicines agency schedules azatadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05645mig. the term azatadine is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules azatadine in its anatomical therapeutic chemical (atc) classification. azatadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azatadine under hs 29333999 and sitc 51574. as of q4 2014, azatadine remains the us fda preferred term for this commodity. azatadine bears us nlm identifiers umls id c0052759 and nci concept code c77430. smiles: n1(cc/c(=c2/c3c(ccc4c2nccc4)cccc3)cc1)c.. "
"antihistamine or h1 blocker dibenzocycloheptenes. antihistamine or h1 blocker drugs made from a family of tricyclic hydrocarbons.. cyproheptadine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h21n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2yhb6175do, chemically known as 5-(1-methylpiperidylidene-4)-5h-dibenzo(a,d)cyclopheptene but generally known as cyproheptadine, which bears us nih compound identifier 2913. european medicines agency schedules cyproheptadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06875mig. the term cyproheptadine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules cyproheptadine in its anatomical therapeutic chemical (atc) classification. cyproheptadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cyproheptadine under hs 29333999 and sitc 51574. as of q4 2014, cyproheptadine remains the us fda preferred term for this commodity. cyproheptadine bears us nlm identifiers umls id c0010620 and nci concept code c61695. smiles: n1(cc/c(=c2/c3c(c=cc4c2cccc4)cccc3)cc1)c.. "
"antihistamine or h1 blocker dibenzocycloheptenes. antihistamine or h1 blocker drugs made from a family of tricyclic hydrocarbons.. desloratadine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h19cln2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fvf865388r, chemically known as 5h-benzo(5,6)cyclohepta(1,2-b)pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)- but generally known as desloratadine, which bears us nih compound identifier 124087. european medicines agency schedules desloratadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01596mig. the term desloratadine is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules desloratadine in its anatomical therapeutic chemical (atc) classification. most nations schedule desloratadine under hs 29333999 and sitc 51574. as of q4 2014, desloratadine remains the us fda preferred term for this commodity. desloratadine bears us nlm identifiers umls id c0908935 and nci concept code c47474. smiles: clc1cc2c(/c(=c3/ccncc3)c3ncccc3cc2)cc1.. "
"antihistamine or h1 blocker dibenzocycloheptenes. antihistamine or h1 blocker drugs made from a family of tricyclic hydrocarbons.. loratadine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c22h23cln2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7ajo3bo7qn, chemically known as 1-piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-, ethyl ester but generally known as loratadine, which bears us nih compound identifier 3957. european medicines agency schedules loratadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08581mig. the term loratadine is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules loratadine in its anatomical therapeutic chemical (atc) classification. loratadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule loratadine under hs 29333999 and sitc 51574. as of q4 2014, loratadine remains the us fda preferred term for this commodity. loratadine bears us nlm identifiers umls id c0065180 and nci concept code c29162. smiles: clc1cc2c(/c(=c3/ccn(cc3)c(=o)occ)c3ncccc3cc2)cc1.. "
"antihistamine or h1 blocker dibenzocycloheptenes. antihistamine or h1 blocker drugs made from a family of tricyclic hydrocarbons.. rupatadine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c26h26cln3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2ae8m83g3e, chemically known as 8-chloro-6,11-dihydro-11-(1-((5-methyl-3-pyridyl)methyl)-4-piperidylidene)-5h-benzo(5,6)cyclohepta(1,2-b)pyridine but generally known as rupatadine, which bears us nih compound identifier 133017. european medicines agency schedules rupatadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10406mig. the term rupatadine is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). world health organization schedules rupatadine in its anatomical therapeutic chemical (atc) classification. rupatadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rupatadine under hs 29333999 and sitc 51574. as of q4 2014, rupatadine remains the us fda preferred term for this commodity. rupatadine bears us nlm identifiers umls id c0534301 and nci concept code c73055. smiles: clc1cc2c(/c(=c3\\ccn(cc3)cc3cc(cnc3)c)c3ncccc3cc2)cc1.. "
"antihistamine or h1 blocker dibenzocycloheptenes. antihistamine or h1 blocker drugs made from a family of tricyclic hydrocarbons.. azatadine dimaleate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c20h22n2.2c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f3q391wtx7, chemically known as 5h-benzo(5,6)cyclohepta(1,2-b)pyridine, 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-, (z)-2-butenedioate (1:2), but more generally known as azatadine dimaleate, which bears us nih compound identifier 5281066. european medicines agency schedules azatadine dimaleate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05645mig. most nations, for tariff purposes, schedule azatadine dimaleate under hs 29333999. smiles: cn1ccc(=c2c3ncccc3ccc4c2cccc4)cc1.c(=c\\c(=o)o)\\c(=o)o.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker dibenzocycloheptenes. antihistamine or h1 blocker drugs made from a family of tricyclic hydrocarbons.. azatadine maleate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c20h22n2.2c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f3q391wtx7, chemically known as 6,11-dihydro-11-(1-methyl-4-piperidylidene)-5h-benzo(5,6)cyclohepta(1,2-b)pyridine but more generally known as azatadine maleate, which bears us nih compound identifier 19861. european medicines agency schedules azatadine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00640mig. most nations, for tariff and trade purposes, schedule azatadine maleate under hs 29333999 and sitc 51574. as of q4 2014, azatadine maleate remains us fdas preferred term for this commodity. azatadine maleate bears us nlm identifiers umls id c0149304 and nci concept code c61642. smiles: cn1ccc(=c2c3ncccc3ccc4c2cccc4)cc1.c(=c\\c(=o)o)\\c(=o)o.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker dibenzocycloheptenes. antihistamine or h1 blocker drugs made from a family of tricyclic hydrocarbons.. cyproheptadine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula 2c21h21n.2clh.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nj82j0f8qc, chemically known as 5-(1-methylpiperidylidene-4)-5h-dibenzo(a,d)cyclopheptene but more generally known as cyproheptadine hydrochloride, which bears us nih compound identifier 2913. european medicines agency schedules cyproheptadine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01537mig. most nations, for tariff and trade purposes, schedule cyproheptadine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, cyproheptadine hydrochloride remains us fdas preferred term for this commodity. cyproheptadine hydrochloride bears us nlm identifiers umls id c0354872 and nci concept code c28949. smiles: cn1ccc(=c2c3ccccc3c=cc4c2cccc4)cc1.cn1ccc(=c2c3ccccc3c=cc4c2cccc4)cc1.o.o.o.cl.cl.. "
"antihistamine or h1 blocker dibenzocycloheptenes. antihistamine or h1 blocker drugs made from a family of tricyclic hydrocarbons.. cyproheptadine hydrochloride sesquihydrate. this classification denotes a histamine-1 receptor antagonist with the molecular formula 2c21h21n.2clh.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nj82j0f8qc, chemically known as piperidine, 4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-, hydrochloride, hydrate (2:2:3), but more generally known as cyproheptadine hydrochloride sesquihydrate, which bears us nih compound identifier 6441505. european medicines agency schedules cyproheptadine hydrochloride sesquihydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06875mig. most nations, for tariff purposes, schedule cyproheptadine hydrochloride sesquihydrate under hs 29333999. smiles: cn1ccc(=c2c3ccccc3c=cc4c2cccc4)cc1.cn1ccc(=c2c3ccccc3c=cc4c2cccc4)cc1.o.o.o.cl.cl.. "
"antihistamine or h1 blocker dibenzocycloheptenes. antihistamine or h1 blocker drugs made from a family of tricyclic hydrocarbons.. rupatadine fumarate. this classification denotes a histamine-1 receptor antagonist c26h26cln3.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xj6ot32m93, chemically known as 5h-benzo(5,6)cyclohepta(1,2-b)pyridine, 8-chloro-6,11-dihydro-11-(1-((5-methyl-3-pyridinyl)methyl)-4-piperidinylidene)-, (2e)-2-butenedioate (1:1), but more generally known as rupatadine fumarate, which bears us nih compound identifier 6449107. european medicines agency schedules rupatadine fumarate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22090. most nations, for tariff and trade purposes, schedule rupatadine fumarate under hs 29333999 and sitc 51574. as of q4 2014, rupatadine fumarate remains us fdas preferred term for this commodity. smiles: cc1cc(cnc1)cn2ccc(=c3c4ccc(cc4ccc5c3nccc5)cl)cc2.c(=c/c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. . "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. bromazine or bromodiphenhydramine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h20brno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t032bi7727, chemically known as ethanamine, 2-((4-bromophenyl)phenylmethoxy)-n,n-dimethyl- but generally known as bromazine, which bears us nih compound identifier 2444. bromazine most often comes in base and hydrochloride forms. european medicines agency schedules bromazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05908mig. the term bromazine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules bromazine in its anatomical therapeutic chemical (atc) classification. bromazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. bromazine or bromodiphenhydramine bears us nlm identifiers umls id c0054120 and nci concept code c61654. smiles: brc1ccc(c(occn(c)c)c2ccccc2)cc1.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. bufenadrine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h29no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9y0t619b3u, chemically known as 2-((o-tert-butyl-alpha-phenyl-benzyl)oxy)-n,n-dimethylethylamine. but generally known as bufenadrine, which bears us nih compound identifier 21916. european medicines agency schedules bufenadrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05959mig. the term bufenadrine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). bufenadrine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bufenadrine under hs 29221980 and sitc 51461. as of q4 2014, bufenadrine remains the us fda preferred term for this commodity. bufenadrine bears us nlm identifiers umls id c2347227 and nci concept code c73046. smiles: o(c(c1c(c(c)(c)c)cccc1)c1ccccc1)ccn(c)c.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. chlorphenoxamine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h22clno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3uvd77bp8r, chemically known as 2-(1-(p-chlorophenyl)-1-phenylethoxy)-n,n-dimethylethylamine but generally known as chlorphenoxamine, which bears us nih compound identifier 6475. european medicines agency schedules chlorphenoxamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06204mig. the term chlorphenoxamine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules chlorphenoxamine in its anatomical therapeutic chemical (atc) classification. chlorphenoxamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule chlorphenoxamine under hs 29221980 and sitc 51461. as of q4 2014, chlorphenoxamine remains the us fda preferred term for this commodity. chlorphenoxamine bears us nlm identifiers umls id c0055468 and nci concept code c81131. smiles: clc1ccc(c(occn(c)c)(c2ccccc2)c)cc1.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. diphenhydramine. this classification denotes a histamine-1 receptor antagonist and antiemetic agent with the molecular formula c17h21no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8gts82s83m, chemically known as 2-(diphenylmethoxy)-n,n-dimethylethylamine hydrochloride but generally known as diphenhydramine, which bears us nih compound identifier 3100. european medicines agency schedules diphenhydramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07211mig. the term diphenhydramine is an international non-proprietary name. world health organization schedules diphenhydramine in its anatomical therapeutic chemical (atc) classification. diphenhydramine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule diphenhydramine under hs 29221980 and sitc 51461. as of q4 2014, diphenhydramine remains the us fda preferred term for this commodity. diphenhydramine bears us nlm identifiers umls id c0012522 and nci concept code c61728. smiles: o(c(c1ccccc1)c1ccccc1)ccn(c)c.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. embramine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h22brno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hh0kd7z416, chemically known as 2-(p-bromo-alpha-methyl-alpha-phenylbenzyloxy)-n,n-dimethylethyl amine but generally known as embramine, which bears us nih compound identifier 19105. european medicines agency schedules embramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06500mig. the term embramine is an international non-proprietary name. embramine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule embramine under hs 29221980 and sitc 51461. as of q4 2014, embramine remains the us fda preferred term for this commodity. embramine bears us nlm identifiers umls id c0059053 and nci concept code c81150. smiles: brc1ccc(c(occn(c)c)(c2ccccc2)c)cc1.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. bromazine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h20brno.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 202j683u97, chemically known as ethanamine, 2-((4-bromophenyl)phenylmethoxy)-n,n-dimethyl- but more generally known as bromazine hydrochloride, which bears us nih compound identifier 2444. european medicines agency schedules bromazine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00871mig. most nations, for tariff and trade purposes, schedule bromazine hydrochloride under hs 29221980. smiles: cn(c)ccoc(c1ccccc1)c2ccc(cc2)br.cl.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. chlorphenoxamine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h22clno.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5i159322py, chemically known as 2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)-n,n-dimethylethylamine hydrochloride but more generally known as chlorphenoxamine hydrochloride, which bears us nih compound identifier 11223. european medicines agency schedules chlorphenoxamine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01250mig. most nations, for tariff and trade purposes, schedule chlorphenoxamine hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, chlorphenoxamine hydrochloride remains us fdas preferred term for this commodity. chlorphenoxamine hydrochloride bears us nlm identifiers umls id c1530321 and nci concept code c76671. smiles: cc(c1ccccc1)(c2ccc(cc2)cl)occn(c)c.cl.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. diphenhydramine citrate. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4od433s209. european medicines agency schedules diphenhydramine citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01768mig. diphenhydramine citrate generally arises in the molecular formula c17h21no.c6h8o7. the term diphenhydramine citrate is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule diphenhydramine citrate under hs 29221980 and sitc 51461. as of q4 2014, diphenhydramine citrate remains us fdas preferred term for this commodity. diphenhydramine citrate bears us nlm identifiers umls id c0282144 and nci concept code c82274. smiles: cn(c)ccoc(c1ccccc1)c2ccccc2.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. diphenhydramine hydrochloride. this classification denotes a histamine-1 receptor antagonist and antiemetic agent with the molecular formula c17h21no.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tc2d6jad40, chemically known as 2-(diphenylmethoxy)-n,n-dimethylethylamine hydrochloride but more generally known as diphenhydramine hcl, which bears us nih compound identifier 3100. european medicines agency schedules diphenhydramine hcl in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01769mig. most nations, for tariff and trade purposes, schedule diphenhydramine hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, diphenhydramine hydrochloride remains us fdas preferred term for this commodity. diphenhydramine hydrochloride bears us nlm identifiers umls id c0004963 and nci concept code c300. smiles: cn(c)ccoc(c1ccccc1)c2ccccc2.cl.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. diphenhydramine laurylsulfate. this classification denotes a histamine-1 receptor antagonist and antiemetic agent with the molecular formula c17h21no.c12h26o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3e2cn035lb, chemically known as ethanamine, 2-(diphenylmethoxy)-n,n-dimethyl-, dodecyl sulfate, but more generally known as diphenhydramine laurylsulfate, which bears us nih compound identifier 9892949. european medicines agency schedules diphenhydramine laurylsulfate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07211mig. most nations, for tariff purposes, schedule diphenhydramine laurylsulfate under hs 29221980. smiles: ccccccccccccos(=o)(=o)o.cn(c)ccoc(c1ccccc1)c2ccccc2.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. diphenhydramine methiodide. this classification denotes a histamine-1 receptor antagonist and antiemetic agent with the molecular formula c18h24no.i, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ctn47n39pr, chemically known as ammonium, (2-(diphenylmethoxy)ethyl)trimethyl-, iodide, but more generally known as diphenhydramine methiodide, which bears us nih compound identifier 26535. european medicines agency schedules diphenhydramine methiodide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07211mig. most nations, for tariff purposes, schedule diphenhydramine methiodide under hs 29221980. smiles: c[n+](c)(c)ccoc(c1ccccc1)c2ccccc2.[i-].. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. diphenhydramine methylbromide. this classification denotes a histamine h1 antagonist, antiemetic, antitussive, and hypnotic with the molecular formula c18h24no.br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ujo67ao8yi, chemically known as ethylamine, n,n-dimethyl-2-(diphenylmethoxy)-, methylbromide but more generally known as diphenhydramine methylbromide, which bears us nih compound identifier 35726. european medicines agency schedules diphenhydramine methylbromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01771mig. world health organization schedules diphenhydramine methylbromide in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule diphenhydramine methylbromide under hs 29221980 and sitc 51461. diphenhydramine methylbromide bears us nlm identifiers umls id c3273576 and nci concept code c97698. smiles: c[n+](c)(c)ccoc(c1ccccc1)c2ccccc2.[br-].. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. diphenhydramine salicylate. this classification denotes a histamine-1 receptor antagonist and antiemetic agent with the molecular formula c17h21no.c7h6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 707l3yc54l, chemically known as 2-(diphenylmethoxy)-n,n-dimethylethylamine hydrochloride but more generally known as diphenhydramine salicylate, which bears us nih compound identifier 3100. european medicines agency schedules diphenhydramine salicylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01774mig. most nations, for tariff and trade purposes, schedule diphenhydramine salicylate under hs 29221980 and sitc 51461. as of q4 2014, diphenhydramine salicylate remains us fdas preferred term for this commodity. smiles: cn(c)ccoc(c1ccccc1)c2ccccc2.c1ccc(c(c1)c(=o)o)o.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. diphenhydramine tannate. this classification denotes a histamine-1 receptor antagonist and antiemetic agent with the molecular formula c76h52o46.c17h21no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier opi52249zg. european medicines agency schedules diphenhydramine tannate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01775mig. most nations, for tariff and trade purposes, schedule diphenhydramine tannate under hs 29221980 and sitc 51461. smiles: as of q4 2014, diphenhydramine tannate remains us fdas preferred term for this commodity.. "
"antihistamine or h1 blocker ethylamines. antihistamine or h1 blocker drugs made from ethanamine or ch3ch2nh2.. embramine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular structure c18h22brno.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 7bj3v657vc chemically known as 2-((p-bromo-.alpha.-methyl-.alpha.-phenylbenzyl)oxy)-n,n-dimethylethylamine hydrochloride, but more commonly known as embramine hydrochloride, which bears us nih compound identifier 26365. european medicines agency schedules embramine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01870mig. most nations, for tariff and trade purposes, schedule embramine hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, embramine hydrochloride remains us fdas preferred term for this commodity. embramine hydrochloride bears us nlm identifiers umls id c0127383 and nci concept code c81132. smiles: cc(c1ccccc1)(c2ccc(cc2)br)occn(c)c.cl.. "
"antihistamine or h1 blocker ethylenediamines. antihistamine or h1 blocker drugs made from an ethylamine, c2h4(nh2)2.. . "
"antihistamine or h1 blocker ethylenediamines. antihistamine or h1 blocker drugs made from an ethylamine, c2h4(nh2)2.. chloropyramine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h20cln3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2k3l8o9sov, chemically known as 1,2-ethanediamine, n-((4-chlorophenyl)methyl)-n,n-dimethyl-n-2-pyridinyl- (9ci) but generally known as chloropyramine, which bears us nih compound identifier 25295. european medicines agency schedules chloropyramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06194mig. the term chloropyramine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules chloropyramine in its anatomical therapeutic chemical (atc) classification. chloropyramine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule chloropyramine under hs 29333999 and sitc 51574. as of q4 2014, chloropyramine remains the us fda preferred term for this commodity. chloropyramine bears us nlm identifiers umls id c0055445 and nci concept code c81130. smiles: clc1ccc(cn(ccn(c)c)c2ncccc2)cc1.. "
"antihistamine or h1 blocker ethylenediamines. antihistamine or h1 blocker drugs made from an ethylamine, c2h4(nh2)2.. methapyrilene. this classification denotes a histamine-1 receptor antagonist with the molecular formula c14h19n3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a01lx40298, chemically known as 1,2-ethanediamine, n,n-dimethyl-n-2-pyridinyl-n-(2-thienylmethyl)- but generally known as methapyrilene, which bears us nih compound identifier 4098. european medicines agency schedules methapyrilene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08839mig. the term methapyrilene is an international non-proprietary name. world health organization schedules methapyrilene in its anatomical therapeutic chemical (atc) classification. methapyrilene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methapyrilene under hs 29349990 and sitc 51579. as of q4 2014, methapyrilene remains the us fda preferred term for this commodity. methapyrilene bears us nlm identifiers umls id c0025625 and nci concept code c81143. smiles: s1c(cn(ccn(c)c)c2ncccc2)ccc1.. "
"antihistamine or h1 blocker ethylenediamines. antihistamine or h1 blocker drugs made from an ethylamine, c2h4(nh2)2.. tripelennamine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h21n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3c5oro99ty, chemically known as 1,2-ethanediamine, n, n-dimethyl-n- (phenylmethyl)-n-2-pyridinyl-, monohydrochloride but generally known as tripelennamine, which bears us nih compound identifier 5587. european medicines agency schedules tripelennamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11322mig. the term tripelennamine is an international non-proprietary name. world health organization schedules tripelennamine in its anatomical therapeutic chemical (atc) classification. tripelennamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tripelennamine under hs 29333999 and sitc 51574. as of q4 2014, tripelennamine remains the us fda preferred term for this commodity. tripelennamine bears us nlm identifiers umls id c0041090 and nci concept code c61991. smiles: n(ccn(c)c)(cc1ccccc1)c1ncccc1.. "
"antihistamine or h1 blocker ethylenediamines. antihistamine or h1 blocker drugs made from an ethylamine, c2h4(nh2)2.. chlorothen. this classification denotes a histamine-1 receptor antagonist with the molecular formula c14h18cln3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y6068k376i, chemically known as 2-((5-chloro-2-thenyl)(2-(dimethylamino)ethyl)amino)pyridine but generally known as chlorothen, which bears us nih compound identifier 8993. european medicines agency schedules chloropyrilene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06195mig. the term chloropyrilene is a u.s. fda designation. as of q4 2014, chlorothen remains the us fda preferred term for this commodity. chlorothen bears us nlm identifiers umls id c0164505 and nci concept code c83621. smiles: cn(c)ccn(cc1=cc=c(s1)cl)c2=cc=cc=n2.. "
"antihistamine or h1 blocker ethylenediamines. antihistamine or h1 blocker drugs made from an ethylamine, c2h4(nh2)2.. chloropyramine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h20cln3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fwa92z14nn, chemically known as 1,2-ethanediamine, n-((4-chlorophenyl)methyl)-n,n-dimethyl-n-2-pyridinyl- (9ci) but more generally known as chloropyramine hydrochloride, which bears us nih compound identifier 25295. european medicines agency schedules chloropyramine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01233mig. most nations, for tariff and trade purposes, schedule chloropyramine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, chloropyramine hydrochloride remains us fdas preferred term for this commodity. chloropyramine hydrochloride bears us nlm identifiers umls id c0771732 and nci concept code c97693. smiles: cn(c)ccn(cc1ccc(cc1)cl)c2ccccn2.cl.. "
"antihistamine or h1 blocker ethylenediamines. antihistamine or h1 blocker drugs made from an ethylamine, c2h4(nh2)2.. methapyrilene fumarate. this classification denotes a histamine-1 receptor antagonist with the molecular structure 2c14h19n3s.3c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, kj5i25txyl chemically known as 1,2-ethanediamine, n,n-dimethyl-n-2-pyridinyl-n-(2-thienylmethyl)-, (e)-2-butenedioate (2:3), but more commonly known as methapyrilene fumarate, which bears us nih compound identifier 6436730. european medicines agency schedules methapyrilene fumarate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14535mig. most nations, for tariff and trade purposes, schedule methapyrilene fumarate under hs 29349990 and sitc 51579. as of q4 2014, methapyrilene fumarate remains us fdas preferred term for this commodity. methapyrilene fumarate bears us nlm identifiers umls id c2064778 and nci concept code c83953. smiles: cn(ccn(c1ncccc1)cc2sccc2)c.cn(ccn(c1ncccc1)cc2sccc2)c.c(=c/c(=o)o)\\c(=o)o.c(=c/c(=o)o)\\c(=o)o.c(=c/c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker ethylenediamines. antihistamine or h1 blocker drugs made from an ethylamine, c2h4(nh2)2.. methapyrilene hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c14h19n3s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 00s42n58om, chemically known as 1,2-ethanediamine, n,n-dimethyl-n-2-pyridinyl-n-(2-thienylmethyl)-, monohydrochloride but more generally known as methapyrilene hydrochloride, which bears us nih compound identifier 8667. european medicines agency schedules methapyrilene hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03211mig. most nations, for tariff and trade purposes, schedule methapyrilene hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, methapyrilene hydrochloride remains us fdas preferred term for this commodity. methapyrilene hydrochloride bears us nlm identifiers umls id c0770858 and nci concept code c81134. smiles: cn(c)ccn(cc1cccs1)c2ccccn2.cl.. "
"antihistamine or h1 blocker ethylenediamines. antihistamine or h1 blocker drugs made from an ethylamine, c2h4(nh2)2.. tripelennamine citrate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h21n3.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 30oc46a3j9, chemically known as 1,2-ethanediamine, n,n-dimethyl-n-(phenylmethyl)-n-2-pyridinyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) but more generally known as tripelennamine citrate, which bears us nih compound identifier 197066. european medicines agency schedules tripelennamine citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04980mig. most nations, for tariff and trade purposes, schedule tripelennamine citrate under hs 29333999 and sitc 51574. as of q4 2014, tripelennamine citrate remains us fdas preferred term for this commodity. tripelennamine citrate bears us nlm identifiers umls id c0242524 and nci concept code c66641. smiles: cn(c)ccn(cc1ccccc1)c2ccccn2.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"antihistamine or h1 blocker ethylenediamines. antihistamine or h1 blocker drugs made from an ethylamine, c2h4(nh2)2.. tripelennamine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h21n3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fwv8gj56zn, chemically known as 1,2-ethanediamine, n, n-dimethyl-n- (phenylmethyl)-n-2-pyridinyl-, monohydrochloride but more generally known as tripelennamine hydrochloride, which bears us nih compound identifier 5587. european medicines agency schedules tripelennamine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04981mig. most nations, for tariff and trade purposes, schedule tripelennamine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, tripelennamine hydrochloride remains us fdas preferred term for this commodity. tripelennamine hydrochloride bears us nlm identifiers umls id c0304297 and nci concept code c47774. smiles: cn(c)ccn(cc1ccccc1)c2ccccn2.cl.. "
"antihistamine or h1 blocker guanidines and indenes and lactams and peptides and quinazolines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on guanidines, indenes, lactams, peptides, or quinazolines. . "
"antihistamine or h1 blocker guanidines and indenes and lactams and peptides and quinazolines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on guanidines, indenes, lactams, peptides, or quinazolines. arpromidine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h25fn6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 85713mt0eh, chemically known as guanidine, n-(3-(4-fluorophenyl)-3-(2-pyridinyl)propyl)-n-(3-(1h-imidazol-4-yl)propyl)- but generally known as arpromidine, which bears us nih compound identifier 65895. european medicines agency schedules arpromidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05570mig. the term arpromidine is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). most nations schedule arpromidine under hs 29333999 and sitc 51574. as of q4 2014, arpromidine remains the us fda preferred term for this commodity. arpromidine bears us nlm identifiers umls id c0052410 and nci concept code c72108. smiles: fc1ccc(c(ccn/c(=n/cccc2[nh]cnc2)n)c2ncccc2)cc1.. "
"antihistamine or h1 blocker guanidines and indenes and lactams and peptides and quinazolines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on guanidines, indenes, lactams, peptides, or quinazolines. clobenzepam. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h18cln3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0o6w0np518, chemically known as 10,11-dihydro-11-oxo-5h-dibenzo(b,e)(1,4)diazepine, 7-chloro-10-(2-(dimethylamino)ethyl)- but generally known as clobenzepam, which bears us nih compound identifier 14396. european medicines agency schedules clobenzepam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06675mig. the term clobenzepam is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). clobenzepam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clobenzepam under hs 29339940 and sitc 51577. as of q4 2014, clobenzepam remains the us fda preferred term for this commodity. clobenzepam bears us nlm identifiers umls id c2699357 and nci concept code c77434. smiles: clc1cc2[nh]c3c(c(=o)n(ccn(c)c)c2cc1)cccc3.. "
"antihistamine or h1 blocker guanidines and indenes and lactams and peptides and quinazolines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on guanidines, indenes, lactams, peptides, or quinazolines. dimethindene or dimetindene. this classification denotes a histamine h1 antagonist, antipruritic, and anti-allergic agent with the molecular formula c20h24n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 661fh77z3p, chemically known as 1h-indene-2-ethanamine, n,n-dimethyl-3-(1-(2-pyridinyl)ethyl)- (9ci) but generally known as dimetindene, which bears us nih compound identifier 21855. european medicines agency schedules dimetindene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07179mig. world health organization schedules dimetindene in its anatomical therapeutic chemical (atc) classification. dimetindene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. dimethindene or dimetindene bears us nlm identifiers umls id c0012390 and nci concept code c83675. smiles: n(ccc1=c(c(c)c2ncccc2)c2c(c1)cccc2)(c)c.. "
"antihistamine or h1 blocker guanidines and indenes and lactams and peptides and quinazolines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on guanidines, indenes, lactams, peptides, or quinazolines. tiacrilast. this classification denotes a histamine-1 receptor antagonist with the molecular formula c12h10n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 74l3dxn051, chemically known as 2-propenoic acid, 3-(6-(methylthio)-4-oxo-3(4h)-quinazolinyl)-, (e)- but generally known as tiacrilast, which bears us nih compound identifier 6435375. european medicines agency schedules tiacrilast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10997mig. the term tiacrilast is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). tiacrilast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tiacrilast under hs 29335995 and sitc 51576. as of q4 2014, tiacrilast remains the us fda preferred term for this commodity. tiacrilast bears us nlm identifiers umls id c0145898 and nci concept code c73059. smiles: csc1=cc2=c(c=c1)n=cn(c2=o)/c=c/c(=o)o.. "
"antihistamine or h1 blocker guanidines and indenes and lactams and peptides and quinazolines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on guanidines, indenes, lactams, peptides, or quinazolines. spaglumic acid. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x81l78b3rb. european medicines agency schedules spaglumic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10609mig. spaglumic acid generally arises in the molecular formula c11h16n2o8. the term spaglumic acid is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18.) most nations schedule spaglumic acid under hs 29241900 and sitc 51471. as of q4 2014, spaglumic acid remains the us fda preferred term for this commodity. spaglumic acid bears us nlm identifiers umls id c2348231 and nci concept code c72084. smiles: cc(=o)n[c@@h](cc(=o)o)c(=o)n[c@@h](ccc(=o)o)c(=o)o.. "
"antihistamine or h1 blocker guanidines and indenes and lactams and peptides and quinazolines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on guanidines, indenes, lactams, peptides, or quinazolines. clobenzepam hydrochloride. this classification denotes a histamine-1 receptor antagonist c17h18cln3o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 618q2flb9r, chemically known as 2-(2-chloro-6-oxo-11h-benzo(b)(1,4)benzodiazepin-5-yl)ethyl-dimethyl-ammonium chloride, but more generally known as clobenzepam hydrochloride, which bears us nih compound identifier 17646. most nations, for tariff and trade purposes, schedule clobenzepam hydrochloride under hs 29339940 and sitc 51577. as of q4 2014, clobenzepam hydrochloride remains us fdas preferred term for this commodity. smiles: cn(c)ccn1c2ccc(cc2nc3ccccc3c1=o)cl.cl.. "
"antihistamine or h1 blocker guanidines and indenes and lactams and peptides and quinazolines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on guanidines, indenes, lactams, peptides, or quinazolines. dimetindene maleate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c20h24n2.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6ll60j9e0o, chemically known as 1h-indene-2-ethanamine, n,n-dimethyl-3-(1-(2-pyridinyl)ethyl)-, (z)-2-butenedioate (1:1) but more generally known as dimethindene maleate, which bears us nih compound identifier 5282414. european medicines agency schedules dimetindene maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01754mig. most nations, for tariff and trade purposes, schedule dimetindene maleate under hs 29333999. smiles: cc(c1ccccn1)c2=c(cc3c2cccc3)ccn(c)c.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker guanidines and indenes and lactams and peptides and quinazolines. this classification denotes antihistamine or h1 blocker drugs made from or based in part on guanidines, indenes, lactams, peptides, or quinazolines. tiacrilast sodium. this classification denotes a histamine-1 receptor antagonist c12h9n2o3s.na.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4pg8a6utdx, chemically known as sodium (e)-6-(methylthio)-4-oxo-3(4h)-quinazolineacrylate, monohydrate, but more generally known as tiacrilast sodium, which bears us nih compound identifier 23665632. most nations, for tariff and trade purposes, schedule tiacrilast sodium under hs 29335995 and sitc 51576. as of q4 2014, tiacrilast sodium remains us fdas preferred term for this commodity. tiacrilast sodium bears us nlm identifiers umls id c2348786 and nci concept code c72862. smiles: csc1ccc2c(c1)c(=o)n(cn2)/c=c/c(=o)[o-].o.[na+].. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. . "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. noberastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h21n5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9hpd98ouwn, chemically known as 3h-imidazo(4,5-b)pyridin-2-amine, 3-((5-methyl-2-furanyl)methyl)-n-4-piperidinyl- but generally known as noberastine, which bears us nih compound identifier 60531. european medicines agency schedules noberastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09337mig. the term noberastine is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). noberastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule noberastine under hs 29349990 and sitc 51579. as of q4 2014, noberastine remains the us fda preferred term for this commodity. noberastine bears us nlm identifiers umls id c0132719 and nci concept code c74582. smiles: o1c(cn2c(nc3ccncc3)nc3c2nccc3)ccc1c.. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. alcaftadine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h21n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7z8o94ecsx. european medicines agency schedules alcaftadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub37833. the term alcaftadine is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 3, 2006, list 56). most nations schedule alcaftadine under hs 29333990 and sitc 51574. as of q4 2014, alcaftadine remains the us fda preferred term for this commodity. alcaftadine bears us nlm identifiers umls id c2348241 and nci concept code c72686. smiles: cn1ccc(=c2c3=cc=cc=c3ccn4c2=nc=c4c=o)cc1.. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. antazoline. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h19n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dha8014ss1, chemically known as 4,5-dihydro-n-phenyl-n-phenylmethyl-1h-imidazole-2-methanamine but generally known as antazoline, which bears us nih compound identifier 2200. antazoline most often comes in base, 7-theophyllineacetate, hydrochloride, mesylate, methanesulfonate, nitrate, and phosphate forms. european medicines agency schedules antazoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05526mig. the term antazoline is an international non-proprietary name. world health organization schedules antazoline in its anatomical therapeutic chemical (atc) classification. antazoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule antazoline under hs 29332990 and sitc 51573. as of q4 2014, antazoline remains the us fda preferred term for this commodity. antazoline bears us nlm identifiers umls id c0003143 and nci concept code c61638. smiles: n(cc1=nccn1)(cc1ccccc1)c1ccccc1.. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. etintidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c12h16n6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, a60z457ssf chemically known as guanidine, n-cyano-n-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)-n-2-propynyl- but generally known as etintidine, which bears us nih compound identifier 150172. european medicines agency schedules etintidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07305mig. the term etintidine is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). most nations schedule etintidine under hs 29332990 and sitc 51573. as of q4 2014, etintidine remains the us fda preferred term for this commodity. etintidine bears us nlm identifiers umls id c0059856 and nci concept code c81154. smiles: cc1=c(n=cn1)csccnc(=ncc#c)nc#n.. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. mifentidine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2f70kf5s0k. european medicines agency schedules mifentidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08955mig. mifentidine generally arises in the molecular formula c13h16n4. the term mifentidine is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) mifentidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mifentidine under hs 29332990 and sitc 51573. as of q4 2014, mifentidine remains the us fda preferred term for this commodity. mifentidine bears us nlm identifiers umls id c0128486 and nci concept code c66149. smiles: n(c1ccc(c2[nh]cnc2)cc1)/c=n/c(c)c.. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. nemazoline. this classification denotes a histamine-1 receptor antagonist and alpha-adrenergic agonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier quv3ycp28r. european medicines agency schedules nemazoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09190mig. nemazoline generally arises in the molecular formula c10h11cl2n3. the term nemazoline is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31.) nemazoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nemazoline under hs 29332990 and sitc 51573. as of q4 2014, nemazoline remains the us fda preferred term for this commodity. nemazoline bears us nlm identifiers umls id c2827281 and nci concept code c83997. smiles: c1cn=c(n1)cc2=cc(=c(c(=c2)cl)n)cl.. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. antazoline hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h19n3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fp8q8f72jh, chemically known as 2-(n-benzylanilino)methyl-2-imidazoline, hydrochloride but more generally known as antazoline hydrochloride, which bears us nih compound identifier 17275. european medicines agency schedules antazoline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00539mig. most nations, for tariff and trade purposes, schedule antazoline hydrochloride under hs 29332990 and sitc 51573. as of q4 2014, antazoline hydrochloride remains us fdas preferred term for this commodity. antazoline hydrochloride bears us nlm identifiers umls id c0282053 and nci concept code c76668. smiles: c1ccc(cc1)cn(cc2=nccn2)c3ccccc3.cl.. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. antazoline mesilate or mesylate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h19n3.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ku470j7ty6. european medicines agency schedules antazoline mesilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00540mig. the term antazoline mesilate is a u.s. fda designation. most nations, for tariff and trade purposes, schedule antazoline mesylate under hs 29332990. as of q4 2014, antazoline mesylate remains us fdas preferred term for this commodity. antazoline mesylate bears us nlm identifiers umls id c0771474 and nci concept code c95311. smiles: cs(=o)(=o)o.c1ccc(cc1)cn(cc2=nccn2)c3ccccc3.. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. antazoline phosphate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h19n3.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vpr5fph326, chemically known as 1h-imidazole-2-methanamine, 4,5-dihydro-n-phenyl-n-(phenylmethyl)-, phosphate (1:1) but more generally known as antazoline phosphate, which bears us nih compound identifier 158798. european medicines agency schedules antazoline phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00541mig. most nations, for tariff and trade purposes, schedule antazoline phosphate under hs 29332990 and sitc 51573. as of q4 2014, antazoline phosphate remains us fdas preferred term for this commodity. antazoline phosphate bears us nlm identifiers umls id c0003144 and nci concept code c47399. smiles: c1ccc(cc1)cn(cc2=nccn2)c3ccccc3.op(=o)(o)o.. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. antazoline sulfate. this classification denotes a histamine-1 receptor antagonist with the molecular formula 2c17h19n3.2h2o.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6t74i07212. european medicines agency schedules antazoline sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00542mig. the term antazoline sulfate is a u.s. fda designation. most nations, for tariff and trade purposes, schedule antazoline sulfate under hs 29332990 and sitc 51573. as of q4 2014, antazoline sulfate remains us fdas preferred term for this commodity. antazoline sulfate bears us nlm identifiers umls id c0770941 and nci concept code c95310. smiles: c1ccc(cc1)cn(cc2=nccn2)c3ccccc3.os(=o)(=o)o.. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. etintidine hydrochloride. this classification denotes a histamine-2 receptor antagonist with the molecular formula c12h16n6s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t20bd719dd, chemically known as guanidine, n-cyano-n-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)-n-2-propynyl-, monohydrochloride but more generally known as etintidine hydrochloride, which bears us nih compound identifier 150171. most nations, for tariff and trade purposes, schedule etintidine hydrochloride under hs 29332990 and sitc 51573. as of q4 2014, etintidine hydrochloride remains us fdas preferred term for this commodity. etintidine hydrochloride bears us nlm identifiers umls id c0955885 and nci concept code c81155. smiles: cc1c(nc[nh]1)csccnc(=nc#n)ncc#c.cl.. "
"antihistamine or h1 blocker imidazoles. antihistamine or h1 blocker drugs made from compounds with a benzene fused to imidazoles.. nemazoline hydrochloride. this classification denotes a histamine-1 receptor antagonist and alpha-adrenergic agonist c10h11cl2n3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ex1kdr36js, chemically known as benzenamine, 2,6-dichloro-4-((4,5-dihydro-1h-imidazol-2-yl)methyl)-, monohydrochloride, but more generally known as nemazoline hydrochloride, which bears us nih compound identifier 60468. most nations, for tariff and trade purposes, schedule nemazoline hydrochloride under hs 29332990 and sitc 51573. as of q4 2014, nemazoline hydrochloride remains us fdas preferred term for this commodity. nemazoline hydrochloride bears us nlm identifiers umls id c0632201 and nci concept code c83998. smiles: c1c(cc(c(c1cl)n)cl)cc2=nccn2.cl.. "
"antihistamine or h1 blocker pyrrolidines. antihistamine or h1 blocker drugs made from tetrahydropyrroles.. . "
"antihistamine or h1 blocker pyrrolidines. antihistamine or h1 blocker drugs made from tetrahydropyrroles.. clemastine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 95qn29s1id. european medicines agency schedules clemastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06648mig. clemastine generally arises in the molecular formula c21h26clno. the term clemastine is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10.) clemastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clemastine under hs 29339990 and sitc 51577. as of q4 2014, clemastine remains the us fda preferred term for this commodity. clemastine bears us nlm identifiers umls id c0008929 and nci concept code c61682. smiles: clc1ccc(c(occc2n(ccc2)c)(c2ccccc2)c)cc1.. "
"antihistamine or h1 blocker pyrrolidines. antihistamine or h1 blocker drugs made from tetrahydropyrroles.. histapyrrodine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0fym61ng4d. european medicines agency schedules histapyrrodine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08044mig. histapyrrodine generally arises in the molecular formula c19h24n2. the term histapyrrodine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3.) histapyrrodine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule histapyrrodine under hs 29339990 and sitc 51577. as of q4 2014, histapyrrodine remains the us fda preferred term for this commodity. histapyrrodine bears us nlm identifiers umls id c0628458 and nci concept code c65855. smiles: n1(cccc1)ccn(cc1ccccc1)c1ccccc1.. "
"antihistamine or h1 blocker pyrrolidines. antihistamine or h1 blocker drugs made from tetrahydropyrroles.. pyrrobutamine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c20h22cln, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ve6kp18s8x, chemically known as pyrrolidine, 1-(4-(4-chlorophenyl)-3-phenyl-2-butenyl)- but generally known as pyrrobutamine, which bears us nih compound identifier 5284614. european medicines agency schedules pyrrobutamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15066mig. world health organization schedules pyrrobutamine in its anatomical therapeutic chemical (atc) classification. as of q4 2014, pyrrobutamine remains the us fda preferred term for this commodity. pyrrobutamine bears us nlm identifiers umls id c0163091 and nci concept code c81146. smiles: clc1ccc(c/c(=c\\cn2cccc2)c2ccccc2)cc1.. "
"antihistamine or h1 blocker pyrrolidines. antihistamine or h1 blocker drugs made from tetrahydropyrroles.. clemastine fumarate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h26clno.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 19259egq3d, chemically known as pyrrolidine, 2-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methyl-, (r-(r*,r*))- but more generally known as clemastine fumarate, which bears us nih compound identifier 26987. european medicines agency schedules clemastine fumarate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01335mig. most nations, for tariff and trade purposes, schedule clemastine fumarate under hs 29339990 and sitc 51577. as of q4 2014, clemastine fumarate remains us fdas preferred term for this commodity. clemastine fumarate bears us nlm identifiers umls id c0546858 and nci concept code c47454. smiles: c[c@@](c1ccccc1)(c2ccc(cc2)cl)occ[c@h]3cccn3c.c(=c/c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker pyrrolidines. antihistamine or h1 blocker drugs made from tetrahydropyrroles.. clemastine hydrogen fumarate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h26clno.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 19259egq3d, chemically known as pyrrolidine, 2-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methyl-, (r-(r*,r*))-, (e)-2-butenedioate (1:1), but more generally known as clemastine hydrogen fumarate, which bears us nih compound identifier 5281069. european medicines agency schedules clemastine hydrogen fumarate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06648mig. most nations, for tariff purposes, schedule clemastine hydrogen fumarate under hs 29339990. smiles: c[c@@](c1ccccc1)(c2ccc(cc2)cl)occ[c@h]3cccn3c.c(=c/c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker pyrrolidines. antihistamine or h1 blocker drugs made from tetrahydropyrroles.. histapyrrodine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h24n2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1w1aq870zc, chemically known as 1-pyrrolidineethanamine, n-phenyl-n-(phenylmethyl)-, monohydrochloride but more generally known as histapyrrodine hydrochloride, which bears us nih compound identifier 160809. european medicines agency schedules histapyrrodine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02526mig. most nations, for tariff and trade purposes, schedule histapyrrodine hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, histapyrrodine hydrochloride remains us fdas preferred term for this commodity. histapyrrodine hydrochloride bears us nlm identifiers umls id c1314666 and nci concept code c97699. smiles: c1ccc(cc1)cn(ccn2cccc2)c3ccccc3.cl.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. . "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. dacemazine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h16n2os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 88d34uy0qi, chemically known as 10-n,n-dimethylglycylphenothiazine but generally known as dacemazine, which bears us nih compound identifier 68846. european medicines agency schedules dacemazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06883mig. the term dacemazine is an international non-proprietary name. dacemazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dacemazine under hs 29343090 and sitc 51578. as of q4 2014, dacemazine remains the us fda preferred term for this commodity. dacemazine bears us nlm identifiers umls id c2348067 and nci concept code c73047. smiles: s1c2c(n(c3c1cccc3)c(=o)cn(c)c)cccc2.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. dimetotiazine. this classification denotes a histamine h1 antagonist and phenothiazine with the molecular formula c19h25n3o2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1fta475zdb, chemically known as 10-(2-(dimethylamino)propyl)-n,n-dimethylphenothiazine-2-sulfonamide but generally known as dimetotiazine, which bears us nih compound identifier 3089. european medicines agency schedules dimetotiazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07182mig. world health organization schedules dimetotiazine in its anatomical therapeutic chemical (atc) classification. dimetotiazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dimetotiazine under hs 29350090 and sitc 51580. smiles: cc(cn1c2=cc=cc=c2sc3=c1c=c(c=c3)s(=o)(=o)n(c)c)n(c)c.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. fenethazine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h18n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8j97cuz4hx, chemically known as 10h-phenothiazine-10-ethanamine, n,n-dimethyl-, monohydrochloride but generally known as fenethazine, which bears us nih compound identifier 68223. european medicines agency schedules fenethazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07558mig. the term fenethazine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). fenethazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fenethazine under hs 29343090 and sitc 51578. as of q4 2014, fenethazine remains the us fda preferred term for this commodity. fenethazine bears us nlm identifiers umls id c0060166 and nci concept code c65646. smiles: s1c2c(n(ccn(c)c)c3c1cccc3)cccc2.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. mequitazine. this classification denotes an anti-allergic agent and bronchodilator with the molecular formula c20h22n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y463242ly2, chemically known as 10h-phenothiazine, 10-(1-azabicyclo(2.2.2)oct-3-ylmethyl)- (9ci) but generally known as mequitazine, which bears us nih compound identifier 4066. european medicines agency schedules mequitazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08766mig. world health organization schedules mequitazine in its anatomical therapeutic chemical (atc) classification. mequitazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mequitazine under hs 29343090 and sitc 51578. as of q4 2014, mequitazine remains the us fda preferred term for this commodity. smiles: s1c2c(n(cc3c4ccn(c3)cc4)c3c1cccc3)cccc2.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. methdilazine. this classification denotes a vasodilating agent with the molecular formula c18h20n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4q13ly9z8x, chemically known as 10h-phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)- but generally known as methdilazine, which bears us nih compound identifier 14677. european medicines agency schedules methdilazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08844mig. the term methdilazine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules methdilazine in its anatomical therapeutic chemical (atc) classification. methdilazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methdilazine under hs 29343090 and sitc 51578. as of q4 2014, methdilazine remains the us fda preferred term for this commodity. methdilazine bears us nlm identifiers umls id c0066101 and nci concept code c66114. smiles: s1c2c(n(cc3ccn(c3)c)c3c1cccc3)cccc2.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. methiomeprazine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h24n2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x2r9qtf0ol, chemically known as 10h-phenothiazine-10-propanamine, n,n, .beta.-trimethyl-2- (methylthio)-, monohydrochloride but generally known as methiomeprazine, which bears us nih compound identifier 26430. european medicines agency schedules methiomeprazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08849mig. the term methiomeprazine is an international non-proprietary name. methiomeprazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methiomeprazine under hs 29343090 and sitc 51578. as of q4 2014, methiomeprazine remains the us fda preferred term for this commodity. methiomeprazine bears us nlm identifiers umls id c0603501 and nci concept code c83955. smiles: s1c2c(n(cc(cn(c)c)c)c3c1cccc3)cc(sc)cc2.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. alimemazine or trimeprazine. this classification denotes a sedative and hypnotic with the molecular formula c18h22n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 76h78mjj52, chemically known as 10h-phenothiazine-10-propanamine, n,n,beta-trimethyl- but generally known as alimemazine, which bears us nih compound identifier 5574. alimemazine most often comes in base, s-dioxide, and tartrate forms. european medicines agency schedules alimemazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05328mig. the term alimemazine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules alimemazine in its anatomical therapeutic chemical (atc) classification. alimemazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. alimemazine or trimeprazine bears us nlm identifiers umls id c0041031 and nci concept code c72677. smiles: cc(cn1c2=cc=cc=c2sc3=cc=cc=c31)cn(c)c.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. mequitamium iodide. this classification denotes a histamine-1 receptor antagonist and antimuscarinic agent with the molecular formula c21h25n2s.i, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 50d69zkz7m, chemically known as 1-azoniabicyclo(2.2.2)octane, 1-methyl-3-(10h-phenothiazin-10-ylmethyl)-, iodide but generally known as mequitamium iodide, which bears us nih compound identifier 72028. european medicines agency schedules mequitamium iodide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08765mig. the term mequitamium iodide is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). most nations schedule mequitamium iodide under hs 29343090 and sitc 51578. as of q4 2014, mequitamium iodide remains the us fda preferred term for this commodity. mequitamium iodide bears us nlm identifiers umls id c0064889 and nci concept code c83919. smiles: c[n+]12ccc(cc1)c(c2)cn3c4=cc=cc=c4sc5=cc=cc=c53.[i-].. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. alimemazine tartrate. this classification denotes a histamine-1 receptor antagonist and antiemetic agent with the molecular formula 2c18h22n2s.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 362nw1ld6z, chemically known as 10h-phenothiazine-10-propanamine n,n,beta-trimethyl-, (r-(r*,r*))-2,3-dihydroxybutanedioate (2:1) but more generally known as alimemazine tartrate, which bears us nih compound identifier 78032. the base compound, alimemazine, also comes in base and s-dioxide forms. european medicines agency schedules alimemazine tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00343mig. most nations, for tariff and trade purposes, schedule alimemazine tartrate under hs 29343000. smiles: cc(cn1c2ccccc2sc3c1cccc3)cn(c)c.cc(cn1c2ccccc2sc3c1cccc3)cn(c)c.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. dimetotiazine mesilate. this classification denotes a serotonin antagonist with the molecular formula c19h25n3o2s2.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b28v86ngnk, chemically known as 10h-phenothiazine-2-sulfonamide, 10-(2-(dimethylamino)propyl)-n,n-dimethyl-, monomethanesulfonate but more generally known as dimetotiazine mesilate, which bears us nih compound identifier 25715. european medicines agency schedules dimetotiazine mesilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01755mig. most nations, for tariff and trade purposes, schedule dimetotiazine mesilate under hs 29350090 and sitc 51580. smiles: cc(cn1c2ccccc2sc3c1cc(cc3)s(=o)(=o)n(c)c)n(c)c.cs(=o)(=o)o.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. fenethazine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h18n2s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 225avg0161, chemically known as 10h-phenothiazine-10-ethanamine, n,n-dimethyl-, monohydrochloride but more generally known as fenethazine hydrochloride, which bears us nih compound identifier 68223. most nations, for tariff and trade purposes, schedule fenethazine hydrochloride under hs 29343090 and sitc 51578. as of q4 2014, fenethazine hydrochloride remains us fdas preferred term for this commodity. smiles: cn(c)ccn1c2ccccc2sc3c1cccc3.cl.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. methdilazine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h20n2s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t0gso02uez, chemically known as 10h-phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)-, monohydrochloride but more generally known as methdilazine hydrochloride, which bears us nih compound identifier 14676. european medicines agency schedules methdilazine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03213mig. most nations, for tariff and trade purposes, schedule methdilazine hydrochloride under hs 29343090 and sitc 51578. as of q4 2014, methdilazine hydrochloride remains us fdas preferred term for this commodity. methdilazine hydrochloride bears us nlm identifiers umls id c0304371 and nci concept code c63950. smiles: cn1ccc(c1)cn2c3ccccc3sc4c2cccc4.cl.. "
"antihistamine or h1 blocker phenothiazines. antihistamine or h1 blocker drugs made from compounds containing dibenzo-1,4-thiazine.. methiomeprazine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h24n2s2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p3v14n8pkw, chemically known as 10h-phenothiazine-10-propanamine, n,n,beta-trimethyl-2-(methylthio)-, monohydrochloride (9ci) but more generally known as methiomeprazine hydrochloride, which bears us nih compound identifier 26429. most nations, for tariff and trade purposes, schedule methiomeprazine hydrochloride under hs 29343090 and sitc 51578. as of q4 2014, methiomeprazine hydrochloride remains us fdas preferred term for this commodity. methiomeprazine hydrochloride bears us nlm identifiers umls id c2825473 and nci concept code c81144. smiles: cc(cn1c2ccccc2sc3c1cc(cc3)sc)cn(c)c.cl.. "
"antihistamine or h1 blocker phenanthrolines. antihistamine or h1 blocker drugs made from 1,10-phenanthroline.. . "
"antihistamine or h1 blocker phenanthrolines. antihistamine or h1 blocker drugs made from 1,10-phenanthroline.. bufrolin. this classification denotes a mast cell stabilizer with the molecular formula c18h16n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 46c1px266n, chemically known as 6-butyl-1,4,7,10-tetrahydro-4,10-dioxo-1,7-phenanthroline-2,8-dicarboxylic acid but generally known as bufrolin, which bears us nih compound identifier 72103. european medicines agency schedules bufrolin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05966mig. the term bufrolin is an international non-proprietary name. bufrolin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bufrolin under hs 29339990 and sitc 51577. as of q4 2014, bufrolin remains the us fda preferred term for this commodity. bufrolin bears us nlm identifiers umls id c0054211 and nci concept code c72940. smiles: o=c1c2c([nh]c(c1)c(=o)o)c(cccc)cc1c2[nh]c(cc1=o)c(=o)o.. "
"antihistamine or h1 blocker phenanthrolines. antihistamine or h1 blocker drugs made from 1,10-phenanthroline.. etoloxamine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nez417265p. european medicines agency schedules etoloxamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07329mig. etoloxamine generally arises in the molecular formula c19h25no. the term etoloxamine is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13.) etoloxamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule etoloxamine under hs 29221980 and sitc 51461. as of q4 2014, etoloxamine remains the us fda preferred term for this commodity. etoloxamine bears us nlm identifiers umls id c0659884 and nci concept code c65594. smiles: o(ccn(cc)cc)c1c(cc2ccccc2)cccc1.. "
"antihistamine or h1 blocker phthalazines. antihistamine or h1 blocker drugs made from benzopyridazines.. . "
"antihistamine or h1 blocker phthalazines. antihistamine or h1 blocker drugs made from benzopyridazines.. azelastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c22h24cln3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zqi909440x, chemically known as 1(2h)-phthalazinone, 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1h-azepin-4-yl)- but generally known as azelastine, which bears us nih compound identifier 2267. azelastine most often comes in base and hydrochloride forms. european medicines agency schedules azelastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05649mig. the term azelastine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules azelastine in its anatomical therapeutic chemical (atc) classification. azelastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azelastine under hs 29339930 and sitc 51577. as of q4 2014, azelastine remains the us fda preferred term for this commodity. azelastine bears us nlm identifiers umls id c0052762 and nci concept code c61643. smiles: clc1ccc(cc2nn(c3cccn(cc3)c)c(=o)c3c2cccc3)cc1.. "
"antihistamine or h1 blocker phthalazines. antihistamine or h1 blocker drugs made from benzopyridazines.. talastine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 49ab2pa48b. european medicines agency schedules talastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10801mig. talastine generally arises in the molecular formula c19h21n3o. the term talastine is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8.) talastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule talastine under hs 29339990 and sitc 51577. as of q4 2014, talastine remains the us fda preferred term for this commodity. talastine bears us nlm identifiers umls id c0084711 and nci concept code c73057. smiles: o=c1n(nc(c2c1cccc2)cc1ccccc1)ccn(c)c.. "
"antihistamine or h1 blocker phthalazines. antihistamine or h1 blocker drugs made from benzopyridazines.. azelastine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c22h24cln3o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0l591qr10i, chemically known as 1(2h)-phthalazinone, 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1h-azepin-4-yl)-, monohydrochloride but more generally known as azelastine hydrochloride, which bears us nih compound identifier 54360. european medicines agency schedules azelastine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00642mig. most nations, for tariff and trade purposes, schedule azelastine hydrochloride under hs 29339930 and sitc 51577. as of q4 2014, azelastine hydrochloride remains us fdas preferred term for this commodity. azelastine hydrochloride bears us nlm identifiers umls id c0771004 and nci concept code c47408. smiles: cn1cccc(cc1)n2c(=o)c3ccccc3c(n2)cc4ccc(cc4)cl.cl.. "
"antihistamine or h1 blocker phthalazines. antihistamine or h1 blocker drugs made from benzopyridazines.. talastine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h21n3o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sbh6tu2vu4, chemically known as 2-(2-(dimethylamino)ethyl)-4-(phenylmethyl)-1(2h)-phthalazinone hydrochloride, but more generally known as talastine hydrochloride, which bears us nih compound identifier 167517. european medicines agency schedules talastine hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10801mig. most nations, for tariff purposes, schedule talastine hydrochloride under hs 29339990. talastine hydrochloride bears us nlm identifiers umls id c0121937 and nci concept code c95238. smiles: cn(c)ccn1c(=o)c2ccccc2c(n1)cc3ccccc3.cl.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. . "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. cetirizine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h25cln2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yo7261me24, chemically known as acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)- but generally known as cetirizine, which bears us nih compound identifier 2678. european medicines agency schedules cetirizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07451mig. the term cetirizine is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules cetirizine in its anatomical therapeutic chemical (atc) classification. cetirizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cetirizine under hs 29335995 and sitc 51576. as of q4 2014, cetirizine remains the us fda preferred term for this commodity. cetirizine bears us nlm identifiers umls id c0055147 and nci concept code c1042. smiles: clc1ccc(c(n2ccn(cc2)ccocc(=o)o)c2ccccc2)cc1.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. chlorcyclizine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h21cln2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m26c4ip44p, chemically known as piperazine, 1- (p-chloro-.alpha.-phenylbenzyl)-4-methyl-, monohydrochloride but generally known as chlorcyclizine, which bears us nih compound identifier 2710. european medicines agency schedules chlorcyclizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06178mig. the term chlorcyclizine is an international non-proprietary name. world health organization schedules chlorcyclizine in its anatomical therapeutic chemical (atc) classification. chlorcyclizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule chlorcyclizine under hs 29335995 and sitc 51576. as of q4 2014, chlorcyclizine remains the us fda preferred term for this commodity. chlorcyclizine bears us nlm identifiers umls id c0008183 and nci concept code c81138. smiles: clc1ccc(c(n2ccn(cc2)c)c2ccccc2)cc1.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. clocinizine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8hqj711kh8. european medicines agency schedules clocinizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06685mig. clocinizine generally arises in the molecular formula c26h27cln2. the term clocinizine is an international non-proprietary name or inn. clocinizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clocinizine under hs 29335995 and sitc 51576. as of q4 2014, clocinizine remains the us fda preferred term for this commodity. clocinizine bears us nlm identifiers umls id c1322002 and nci concept code c77435. smiles: clc1ccc(c(n2ccn(cc2)c/c=c/c2ccccc2)c2ccccc2)cc1.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. homochlorcyclizine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h23cln2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n5mvc31w2n, chemically known as 1-(p-chloro-.alpha.-phenylbenzyl)hexahydro-4-methyl-1h-1, 4-diazepine, dihydrochloride but generally known as homochlorcyclizine, which bears us nih compound identifier 3627. european medicines agency schedules homochlorcyclizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08050mig. the term homochlorcyclizine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). homochlorcyclizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule homochlorcyclizine under hs 29339940 and sitc 51577. as of q4 2014, homochlorcyclizine remains the us fda preferred term for this commodity. homochlorcyclizine bears us nlm identifiers umls id c0163772 and nci concept code c81142. smiles: clc1ccc(c(n2cccn(cc2)c)c2ccccc2)cc1.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. hydroxyzine embonate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h27cln2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 30s50ym8og, chemically known as ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)- but generally known as hydroxyzine, which bears us nih compound identifier 3658. european medicines agency schedules hydroxyzine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08088mig. the term hydroxyzine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules hydroxyzine in its anatomical therapeutic chemical (atc) classification. hydroxyzine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule hydroxyzine embonate under hs 29335995 and sitc 51576. smiles: clc1ccc(c(n2ccn(cc2)ccocco)c2ccccc2)cc1.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. levocetirizine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h25cln2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6u5ea9rt2o, chemically known as acetic acid, (2-(4-((r)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)- but generally known as levocetirizine, which bears us nih compound identifier 1549000. european medicines agency schedules levocetirizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08467mig. the term levocetirizine is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). world health organization schedules levocetirizine in its anatomical therapeutic chemical (atc) classification. most nations schedule levocetirizine under hs 29335995 and sitc 51576. as of q4 2014, levocetirizine remains the us fda preferred term for this commodity. levocetirizine bears us nlm identifiers umls id c1174893 and nci concept code c66008. smiles: clc1ccc(c(n2ccn(cc2)ccocc(=o)o)c2ccccc2)cc1.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. oxatomide. this classification denotes a histamine-1 receptor antagonist with the molecular formula c27h30n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j31il9z2ee, chemically known as 2h-benzimidazol-2-one, 1,3-dihydro-1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)- but generally known as oxatomide, which bears us nih compound identifier 4615. european medicines agency schedules oxatomide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09504mig. the term oxatomide is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules oxatomide in its anatomical therapeutic chemical (atc) classification. oxatomide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxatomide under hs 29335995 and sitc 51576. as of q4 2014, oxatomide remains the us fda preferred term for this commodity. oxatomide bears us nlm identifiers umls id c0134337 and nci concept code c73051. smiles: o=c1n(cccn2ccn(cc2)c(c2ccccc2)c2ccccc2)c2c([nh]1)cccc2.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. buclizine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c28h33cln2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0c94v6x681, chemically known as piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-.alpha.-phenylbenzyl)-, dihydrochloride but generally known as buclizine, which bears us nih compound identifier 6729. buclizine most often comes in base, dihydrochloride, and hydrochloride forms. european medicines agency schedules buclizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05947mig. the term buclizine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules buclizine in its anatomical therapeutic chemical (atc) classification. buclizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule buclizine under hs 29335995 and sitc 51576. as of q4 2014, buclizine remains the us fda preferred term for this commodity. buclizine bears us nlm identifiers umls id c0164386 and nci concept code c65273. smiles: clc1ccc(c(n2ccn(cc2)cc2ccc(c(c)(c)c)cc2)c2ccccc2)cc1.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. buclizine dihydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c28h33cln2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 58fqd093nu, chemically known as piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-, dihydrochloride, but more generally known as buclizine dihydrochloride, which bears us nih compound identifier 6729. european medicines agency schedules buclizine dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05947mig. most nations, for tariff purposes, schedule buclizine dihydrochloride under hs 29335995. smiles: cc(c)(c)c1ccc(cc1)cn2ccn(cc2)c(c3ccccc3)c4ccc(cc4)cl.cl.cl.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. buclizine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c28h33cln2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 58fqd093nu, chemically known as piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-.alpha.-phenylbenzyl)-, dihydrochloride but more generally known as buclizine hydrochloride, which bears us nih compound identifier 6729. european medicines agency schedules buclizine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00889mig. most nations, for tariff and trade purposes, schedule buclizine hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, buclizine hydrochloride remains us fdas preferred term for this commodity. buclizine hydrochloride bears us nlm identifiers umls id c0304304 and nci concept code c65274. smiles: cc(c)(c)c1ccc(cc1)cn2ccn(cc2)c(c3ccccc3)c4ccc(cc4)cl.cl.cl.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. cetirizine dihydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h25cln2o3.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 64o047ktoa, chemically known as acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)- but more generally known as cetirizine dihydrochloride, which bears us nih compound identifier 55182. european medicines agency schedules cetirizine dihydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11803mig. most nations, for tariff and trade purposes, schedule cetirizine dihydrochloride under hs 29335995. smiles: c1ccc(cc1)c(c2ccc(cc2)cl)n3ccn(cc3)ccocc(=o)o.cl.cl.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. cetirizine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h25cln2o3.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 64o047ktoa, chemically known as acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)- but more generally known as cetirizine dihydrochloride, which bears us nih compound identifier 55182. european medicines agency schedules cetirizine dihydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11803mig. most nations, for tariff and trade purposes, schedule cetirizine hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, cetirizine hydrochloride remains us fdas preferred term for this commodity. cetirizine hydrochloride bears us nlm identifiers umls id c0700480 and nci concept code c28920. smiles: c1ccc(cc1)c(c2ccc(cc2)cl)n3ccn(cc3)ccocc(=o)o.cl.cl.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. chlorcyclizine dihydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h21cln2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 61y56t95yl, chemically known as piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, hydrochloride (1:2), but more generally known as chlorcyclizine dihydrochloride, which bears us nih compound identifier 101605. european medicines agency schedules chlorcyclizine dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06178mig. most nations, for tariff purposes, schedule chlorcyclizine dihydrochloride under hs 29335995. smiles: cn1ccn(cc1)c(c2ccccc2)c3ccc(cc3)cl.cl.cl.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. chlorcyclizine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h21cln2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier npb7a7874u, chemically known as piperazine, 1- (p-chloro-.alpha.-phenylbenzyl)-4-methyl-, monohydrochloride but more generally known as chlorcyclizine hydrochloride, which bears us nih compound identifier 2710. european medicines agency schedules chlorcyclizine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01212mig. most nations, for tariff and trade purposes, schedule chlorcyclizine hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, chlorcyclizine hydrochloride remains us fdas preferred term for this commodity. chlorcyclizine hydrochloride bears us nlm identifiers umls id c0770863 and nci concept code c76669. smiles: cn1ccn(cc1)c(c2ccccc2)c3ccc(cc3)cl.cl.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. chlorcyclizine monohydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h21cln2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier npb7a7874u, chemically known as piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-methyl-, monohydrochloride, but more generally known as chlorcyclizine monohydrochloride, which bears us nih compound identifier 62413. european medicines agency schedules chlorcyclizine monohydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06178mig. most nations, for tariff purposes, schedule chlorcyclizine monohydrochloride under hs 29335995. smiles: cn1ccn(cc1)c(c2ccccc2)c3ccc(cc3)cl.cl.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. chlorcyclizine pamoate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c23h16o6.c18h21cln2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 73r47nss6p, chemically known as 2-naphthalenecarboxylic acid, 4,4-methylenebis 3-hydroxy-, compd. with 1-((4-chlorophenyl)phenylmethyl)-4-methylpiperazine, but more generally known as chlorcyclizine pamoate, which bears us nih compound identifier 24296. european medicines agency schedules chlorcyclizine pamoate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06178mig. most nations, for tariff purposes, schedule chlorcyclizine pamoate under hs 29335995. smiles: cn1ccn(cc1)c(c2ccccc2)c3ccc(cc3)cl.c1ccc2c(c1)cc(c(c2cc3c4ccccc4cc(c3o)c(=o)o)o)c(=o)o.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. clocinizine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c26h27cln2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ae8km1qu3q. european medicines agency schedules clocinizine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01350mig. the term clocinizine hydrochloride is a u.s. fda designation. most nations, for tariff and trade purposes, schedule clocinizine hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, clocinizine hydrochloride remains us fdas preferred term for this commodity. clocinizine hydrochloride bears us nlm identifiers umls id c3273574 and nci concept code c97696. smiles: c1ccc(cc1)/c=c/cn2ccn(cc2)c(c3ccccc3)c4ccc(cc4)cl.cl.cl.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. homochlorcyclizine dihydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h23cln2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m1ye3tk8na, chemically known as (+/-)-homochlorcyclizine dihydrochloride, but more generally known as homochlorcyclizine dihydrochloride, which bears us nih compound identifier 16114. european medicines agency schedules homochlorcyclizine dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08050mig. most nations, for tariff purposes, schedule homochlorcyclizine dihydrochloride under hs 29339940. smiles: cn1cccn(cc1)c(c2ccccc2)c3ccc(cc3)cl.cl.cl.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. homochlorcyclizine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h23cln2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m1ye3tk8na, chemically known as (+/-)-homochlorcyclizine dihydrochloride, but more generally known as homochlorcyclizine hydrochloride, which bears us nih compound identifier 32313. european medicines agency schedules homochlorcyclizine hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08050mig. most nations, for tariff purposes, schedule homochlorcyclizine hydrochloride under hs 29339940. smiles: cn1cccn(cc1)c(c2ccccc2)c3ccc(cc3)cl.cl.cl.. "
"antihistamine or h1 blocker piperazines. antihistamine or h1 blocker drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. levocetirizine dihydrochloride. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sod6a38aga. european medicines agency schedules levocetirizine dihydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20474. levocetirizine dihydrochloride generally arises in the molecular formula c21h25cln2o3.2clh. the term levocetirizine dihydrochloride is a united states adopted name designation. most nations, for tariff and trade purposes, schedule levocetirizine dihydrochloride under hs 29335995 and sitc 51576. as of q4 2014, levocetirizine dihydrochloride remains us fdas preferred term for this commodity. levocetirizine dihydrochloride bears us nlm identifiers umls id c1311681 and nci concept code c72814. smiles: c1ccc(cc1)[c@h](c2ccc(cc2)cl)n3ccn(cc3)ccocc(=o)o.cl.cl.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. . "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. piprinhydrinate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h23no.c7h7cln4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier si78rfj7xi, chemically known as theophylline, 8-chloro-, compd. with 4-(diphenylmethoxy)-1-methylpiperidine (1:1) but generally known as piprinhydrinate, which bears us nih compound identifier 71640. european medicines agency schedules piprinhydrinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09886mig. the term piprinhydrinate is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). piprinhydrinate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule piprinhydrinate under hs 29395900 and sitc 54145. as of q4 2014, piprinhydrinate remains the us fda preferred term for this commodity. piprinhydrinate bears us nlm identifiers umls id c0771945 and nci concept code c66408. smiles: clc1[nh]c2c(n(c(=o)n(c2=o)c)c)n1.o(c1ccn(cc1)c)c(c1ccccc1)c1ccccc1.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. bamipine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h24n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y6bhz28o92, chemically known as 4-piperidinamine, 1-methyl-n-phenyl-n-(phenylmethyl)- but generally known as bamipine, which bears us nih compound identifier 72075. bamipine most often comes in base, dihydrochloride, and hydrochloride forms. european medicines agency schedules bamipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06098mig. the term bamipine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules bamipine in its anatomical therapeutic chemical (atc) classification. bamipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bamipine under hs 29333999 and sitc 51574. as of q4 2014, bamipine remains the us fda preferred term for this commodity. bamipine bears us nlm identifiers umls id c0052946 and nci concept code c76058. smiles: n1(ccc(n(cc2ccccc2)c2ccccc2)cc1)c.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. bepotastine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hyd2u48ias. european medicines agency schedules bepotastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05778mig. bepotastine generally arises in the molecular formula c21h25cln2o3. the term bepotastine is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40.) most nations schedule bepotastine under hs 29333999 and sitc 51574. as of q4 2014, bepotastine remains the us fda preferred term for this commodity. bepotastine bears us nlm identifiers umls id c2698371 and nci concept code c77431. smiles: c1cn(ccc1o[c@@h](c2=cc=c(c=c2)cl)c3=cc=cc=n3)cccc(=o)o.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. diphenylpyraline. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h23no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 33361oe3av, chemically known as piperidine, 4- (diphenylmethoxy)-1-methyl-, hydrochloride but generally known as diphenylpyraline, which bears us nih compound identifier 3103. european medicines agency schedules diphenylpyraline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07213mig. the term diphenylpyraline is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules diphenylpyraline in its anatomical therapeutic chemical (atc) classification. diphenylpyraline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule diphenylpyraline under hs 29333999 and sitc 51574. as of q4 2014, diphenylpyraline remains the us fda preferred term for this commodity. diphenylpyraline bears us nlm identifiers umls id c0058389 and nci concept code c65423. smiles: o(c1ccn(cc1)c)c(c1ccccc1)c1ccccc1.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. levocabastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c26h29fn2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h68bp06s81, chemically known as 4-piperidinecarboxylic acid, 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, (3s-(1(cis),3alpha,4beta))- but generally known as levocabastine, which bears us nih compound identifier 54385. european medicines agency schedules levocabastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08465mig. the term levocabastine is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules levocabastine in its anatomical therapeutic chemical (atc) classification. levocabastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule levocabastine under hs 29333999 and sitc 51574. as of q4 2014, levocabastine remains the us fda preferred term for this commodity. levocabastine bears us nlm identifiers umls id c0064870 and nci concept code c61806. smiles: fc1ccc(c2(ccc(n3cc(c(cc3)(c3ccccc3)c(=o)o)c)cc2)c#n)cc1.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. pimethixene. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h19ns, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t46j20j26f, chemically known as piperidine, 1-methyl-4-thioxanthen-9-ylidene- but generally known as pimethixene, which bears us nih compound identifier 4822. european medicines agency schedules pimethixene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09840mig. the term pimethixene is an international non-proprietary name. world health organization schedules pimethixene in its anatomical therapeutic chemical (atc) classification. pimethixene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pimethixene under hs 29349990 and sitc 51579. as of q4 2014, pimethixene remains the us fda preferred term for this commodity. pimethixene bears us nlm identifiers umls id c0071069 and nci concept code c82276. smiles: s1c2c(/c(=c3/ccn(cc3)c)c3c1cccc3)cccc2.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. terfenadine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c32h41no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7ba5g9y06q, chemically known as 1-piperidinebutanol, alpha-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)- but generally known as terfenadine, which bears us nih compound identifier 5405. european medicines agency schedules terfenadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10920mig. the term terfenadine is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules terfenadine in its anatomical therapeutic chemical (atc) classification. terfenadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule terfenadine under hs 29333999 and sitc 51574. as of q4 2014, terfenadine remains the us fda preferred term for this commodity. terfenadine bears us nlm identifiers umls id c0085173 and nci concept code c29494. smiles: oc(c1ccn(cc1)cccc(o)c1ccc(c(c)(c)c)cc1)(c1ccccc1)c1ccccc1.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. tenaldin or thenaldine or thenalidine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h22n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6u94n2d00f, chemically known as 4-piperidinamine, 1-methyl-n-phenyl-n-(2-thienylmethyl)- (9ci) but generally known as thenaldine, which bears us nih compound identifier 27901. european medicines agency schedules thenalidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10960mig. the term thenalidine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules thenaldine in its anatomical therapeutic chemical (atc) classification. smiles: cn1ccc(cc1)n(cc2=cc=cs2)c3=cc=cc=c3.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. pirdonium. this classification denotes a histamine-1 receptor antagonist with the molecular formula c22h30no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qle9a8yf1u, chemically known as 1,1-dimethyl-2-(((p-methyl-alpha-phenylbenzyl)oxy)methyl)piperidinium but generally known as pirdonium, which bears us nih compound identifier 3047852. european medicines agency schedules pirdonium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09901mig. the term pirdonium is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). as of q4 2014, pirdonium remains the us fda preferred term for this commodity. pirdonium bears us nlm identifiers umls id c2981353 and nci concept code c87747. smiles: cc1=cc=c(c=c1)c(c2=cc=cc=c2)occ3cccc[n+]3(c)c.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. cycliramine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h19cln2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n61ytn00ck, chemically known as 4-(p-chloro-.alpha.-2-pyridylbenzylidene)-1-methylpiperidine but generally known as cycliramine, which bears us nih compound identifier 5357113. the term cycliramine is an international non-proprietary name or inn. european medicines agency schedules cycliramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06846mig. most nations schedule cycliramine under hs 29333999 and sitc 51574. as of q4 2014, cycliramine remains the us fda preferred term for this commodity. cycliramine bears us nlm identifiers umls id c2828319 and nci concept code c87479. smiles: cn1ccc(=c(c2=cc=c(c=c2)cl)c3=cc=cc=n3)cc1.c(=cc(=o)o)c(=o)o.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. bamipine dihydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h24n2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rg2uz22fez, chemically known as 4-piperidinamine, 1-methyl-n-phenyl-n-(phenylmethyl)-, dihydrochloride, but more generally known as bamipine dihydrochloride, which bears us nih compound identifier 109130. european medicines agency schedules bamipine dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06098mig. most nations, for tariff purposes, schedule bamipine dihydrochloride under hs 29333999. bamipine dihydrochloride bears us nlm identifiers umls id c0953071 and nci concept code c103224. smiles: cn1ccc(cc1)n(cc2ccccc2)c3ccccc3.cl.cl.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. bamipine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h24n2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4k9380352i, chemically known as piperidine, 4-(n-benzyl-n-phenylamino)-1-methyl-, dihydrochloride but more generally known as bamipine hydrochloride, which bears us nih compound identifier 109130. european medicines agency schedules bamipine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00662mig. most nations, for tariff and trade purposes, schedule bamipine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, bamipine hydrochloride remains us fdas preferred term for this commodity. smiles: cn1ccc(cc1)n(cc2ccccc2)c3ccccc3.cl.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. bamipine lactate. this classification denotes a histamine-1 receptor antagonist c19h24n2.c3h6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6k8knj07d8, chemically known as propanoic acid, 2-hydroxy-, compd. with 1-methyl-n-phenyl-n-(phenylmethyl)-4-piperidinamine (1:1), but more generally known as bamipine lactate, which bears us nih compound identifier 11462853. european medicines agency schedules bamipine lactate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00663mig. most nations, for tariff and trade purposes, schedule bamipine lactate under hs 29333999 and sitc 51574. as of q4 2014, bamipine lactate remains us fdas preferred term for this commodity. bamipine lactate bears us nlm identifiers umls id c0771814 and nci concept code c97686. smiles: cc(c(=o)o)o.cn1ccc(cc1)n(cc2ccccc2)c3ccccc3.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. bamipine salicylate. this classification denotes a histamine-1 receptor antagonist c19h24n2.c7h6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2d7769ly0r, chemically known as benzoic acid, 2-hydroxy-, compd. with 1-methyl-n-phenyl-n-(phenylmethyl)-4-piperidinamine, but more generally known as bamipine salicylate, which bears us nih compound identifier 6453348. european medicines agency schedules bamipine salicylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12982mig. most nations, for tariff and trade purposes, schedule bamipine salicylate under hs 29333999 and sitc 51574. as of q4 2014, bamipine salicylate remains us fdas preferred term for this commodity. smiles: cn1ccc(cc1)n(cc2ccccc2)c3ccccc3.c1ccc(c(c1)c(=o)o)o.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. bepotastine besilate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h25cln2o3.c6h6o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6w18mo1qr3. european medicines agency schedules bepotastine besilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05778mig. the term bepotastine besilate is a japanese accepted name designation. most nations, for tariff and trade purposes, schedule bepotastine besilate under hs 29333999 and sitc 51574. as of q4 2014, bepotastine besilate remains us fdas preferred term for this commodity. bepotastine besilate bears us nlm identifiers umls id c1723019 and nci concept code c83550. smiles: c1ccc(cc1)s(=o)(=o)o.c1ccnc(c1)[c@h](c2ccc(cc2)cl)oc3ccn(cc3)cccc(=o)o.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. cycliramine maleate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h19cln2.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j542bcr0iq. the term cycliramine maleate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule cycliramine maleate under hs 29333999 and sitc 51574. as of q4 2014, cycliramine maleate remains us fdas preferred term for this commodity. cycliramine maleate bears us nlm identifiers umls id c1880204 and nci concept code c65355. smiles: cn1ccc(=c(c2ccc(cc2)cl)c3ccccn3)cc1.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. diphenylpyraline hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h23no.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g9fu7f1e87, chemically known as piperidine, 4- (diphenylmethoxy)-1-methyl-, hydrochloride but more generally known as diphenylpyraline hydrochloride, which bears us nih compound identifier 3103. european medicines agency schedules diphenylpyraline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01778mig. most nations, for tariff and trade purposes, schedule diphenylpyraline hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, diphenylpyraline hydrochloride remains us fdas preferred term for this commodity. diphenylpyraline hydrochloride bears us nlm identifiers umls id c0700485 and nci concept code c65424. smiles: cn1ccc(cc1)oc(c2ccccc2)c3ccccc3.cl.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. levocabastine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c26h29fn2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 124xma6yei, chemically known as 4-piperidinecarboxylic acid, 1-(cis-4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, monohydrochloride, (3s,4r)- but more generally known as levocabastine hydrochloride, which bears us nih compound identifier 54384. european medicines agency schedules levocabastine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02905mig. most nations, for tariff and trade purposes, schedule levocabastine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, levocabastine hydrochloride remains us fdas preferred term for this commodity. levocabastine hydrochloride bears us nlm identifiers umls id c0244861 and nci concept code c47582. smiles: c[c@h]1[c@@](ccn(c1)[c@h]2cc[c@@](cc2)(c3ccc(cc3)f)c#n)(c(=o)o)c4ccccc4.cl.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. pimethixene maleate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h19ns.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u22u244m9x, chemically known as thioxanthene, 9-(1-methyl-4-piperidylene)-, maleate but more generally known as pimethixene maleate, which bears us nih compound identifier 5702167. most nations, for tariff and trade purposes, schedule pimethixene maleate under hs 29349990 and sitc 51579. as of q4 2014, pimethixene maleate remains us fdas preferred term for this commodity. pimethixene maleate bears us nlm identifiers umls id c3273580 and nci concept code c97703. smiles: cn1ccc(=c2c3ccccc3sc4c2cccc4)cc1.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker piperidines. antihistamine or h1 blocker drugs made from from a family of hexahydropyridines.. pirdonium bromide. this classification denotes a histamine-1 receptor antagonist with the molecular formula c22h30no.br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5123q291s5, chemically known as 1,1-dimethyl-2-(((p-methyl-alpha-phenylbenzyl)oxy)methyl)piperidinium bromide but more generally known as pirdonium bromide, which bears us nih compound identifier 3047852. european medicines agency schedules pirdonium bromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09901mig. the term pirdonium bromide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 27, no. 10 1973, list 13). most nations, for tariff and trade purposes, schedule pirdonium bromide under hs 29333999 and sitc 51574. as of q4 2014, pirdonium bromide remains us fdas preferred term for this commodity. pirdonium bromide bears us nlm identifiers umls id c1882393 and nci concept code c66415. smiles: cc1ccc(cc1)c(c2ccccc2)occ3cccc[n+]3(c)c.[br-].. "
"antihistamine or h1 blocker propylamines. antihistamine or h1 blocker drugs made from n-propylamine, an amine, c3h9n.. . "
"antihistamine or h1 blocker propylamines. antihistamine or h1 blocker drugs made from n-propylamine, an amine, c3h9n.. promethazine. this classification denotes a phenothiazine with the molecular formula c17h20n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ff28ejq494, chemically known as 10h-phenothiazine-10-ethanamine, n,n,alpha-trimethyl-, radical ion(1+) but generally known as promethazine, which bears us nih compound identifier 4927. european medicines agency schedules promethazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10088mig. the term promethazine is an international non-proprietary name. world health organization schedules promethazine in its anatomical therapeutic chemical (atc) classification. promethazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule promethazine under hs 29343090 and sitc 51578. as of q4 2014, promethazine remains the us fda preferred term for this commodity. promethazine bears us nlm identifiers umls id c0033405 and nci concept code c779. smiles: s1c2c(n(cc(n(c)c)c)c3c1cccc3)cccc2.. "
"antihistamine or h1 blocker propylamines. antihistamine or h1 blocker drugs made from n-propylamine, an amine, c3h9n.. thiazinam or thiazinamium. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h23n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 666w2p28n2, chemically known as 10h-phenothiazine-10-ethanaminium, n,n,n,alpha-tetramethyl-, methyl sulfate but generally known as thiazinamium, which bears us nih compound identifier 6015. european medicines agency schedules thiazinamium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15532mig. as of q4 2014, thiazinamium remains the us fda preferred term for this commodity. thiazinamium bears us nlm identifiers umls id c0039857 and nci concept code c84203. smiles: s1c2c(n(cc([n](c)(c)c)c)c3c1cccc3)cccc2.s(=o)(=o)(oc)o.. "
"antihistamine or h1 blocker propylamines. antihistamine or h1 blocker drugs made from n-propylamine, an amine, c3h9n.. tolpropamine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h23n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tbz8909kfs, chemically known as n,n-dimethyl-3-phenyl-3-p-tolylpropylamine but generally known as tolpropamine, which bears us nih compound identifier 72141. european medicines agency schedules tolpropamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11176mig. the term tolpropamine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules tolpropamine in its anatomical therapeutic chemical (atc) classification. tolpropamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tolpropamine under hs 29214980 and sitc 51454. as of q4 2014, tolpropamine remains the us fda preferred term for this commodity. tolpropamine bears us nlm identifiers umls id c0076805 and nci concept code c90861. smiles: n(ccc(c1ccc(cc1)c)c1ccccc1)(c)c.. "
"antihistamine or h1 blocker propylamines. antihistamine or h1 blocker drugs made from n-propylamine, an amine, c3h9n.. promethazine hydrobromide. this classification denotes a phenothiazine c17h20n2s.brh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0h7q13127s, chemically known as 10h-phenothiazine-10-ethanamine, n,n,.alpha.-trimethyl-, hbr (1:1), but more generally known as promethazine hydrobromide, which bears us nih compound identifier 56841706. most nations, for tariff and trade purposes, schedule promethazine hydrobromide under hs 29343090 and sitc 51578. as of q4 2014, promethazine hydrobromide remains us fdas preferred term for this commodity. promethazine hydrobromide bears us nlm identifiers umls id c0982361 and nci concept code c97704. smiles: cc(cn1c2ccccc2sc3c1cccc3)n(c)c.br.. "
"antihistamine or h1 blocker propylamines. antihistamine or h1 blocker drugs made from n-propylamine, an amine, c3h9n.. promethazine hydrochloride. this classification denotes a phenothiazine with the molecular formula c17h20n2s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r61zeh7i1i, chemically known as 10h-phenothiazine-10-ethanamine, n,n,alpha-trimethyl-, radical ion(1+) but more generally known as promethazine hydrochloride, which bears us nih compound identifier 4927. european medicines agency schedules promethazine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04070mig. most nations, for tariff and trade purposes, schedule promethazine hydrochloride under hs 29343090 and sitc 51578. as of q4 2014, promethazine hydrochloride remains us fdas preferred term for this commodity. promethazine hydrochloride bears us nlm identifiers umls id c0591971 and nci concept code c45907. smiles: cc(cn1c2ccccc2sc3c1cccc3)n(c)c.cl.. "
"antihistamine or h1 blocker propylamines. antihistamine or h1 blocker drugs made from n-propylamine, an amine, c3h9n.. promethazine sulfoxide. this classification denotes a phenothiazine with the molecular formula c17h20n2os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g44a4px06u, chemically known as n-(2-(dimethylamino)propyl)phenothiazine s-oxide, but more generally known as promethazine sulfoxide, which bears us nih compound identifier 63032. european medicines agency schedules promethazine sulfoxide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10088mig. most nations, for tariff purposes, schedule promethazine sulfoxide under hs 29343090. smiles: cc(cn1c2ccccc2[s+](c3c1cccc3)[o-])n(c)c.. "
"antihistamine or h1 blocker propylamines. antihistamine or h1 blocker drugs made from n-propylamine, an amine, c3h9n.. promethazine teoclate. this classification denotes a phenothiazine and antipsychotic agent with the molecular formula c17h20n2s.c7h7cln4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s5pup23u26, chemically known as 8-chloro-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione compd. with n,n,alpha-trimethyl-10h-phenothiazine-10-ethanamine (1:1) but more generally known as promethazine teoclate, which bears us nih compound identifier 63030. european medicines agency schedules promethazine teoclate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10089mig. the term promethazine teoclate is an international non-proprietary name. most nations, for tariff and trade purposes, schedule promethazine teoclate under hs 29395900 and sitc 54145. as of q4 2014, promethazine teoclate remains us fdas preferred term for this commodity. promethazine teoclate bears us nlm identifiers umls id c0355411 and nci concept code c66479. smiles: cc(cn1c2ccccc2sc3c1cccc3)n(c)c.cn1c2c(c(=o)n(c1=o)c)[nh]c(n2)cl.. "
"antihistamine or h1 blocker propylamines. antihistamine or h1 blocker drugs made from n-propylamine, an amine, c3h9n.. thiazinamium metilsulfate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h23n2s.ch3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ia16wbx317, chemically known as 10h-phenothiazine-10-ethanaminium, n,n,n,alpha-tetramethyl-, methyl sulfate but more generally known as thiazinamium methylsulfate, which bears us nih compound identifier 6015. european medicines agency schedules thiazinamium metilsulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10971mig. the term thiazinamium metilsulfate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 31, no10, 1977, list 17). most nations, for tariff and trade purposes, schedule thiazinamium metilsulfate under hs 29343090 and sitc 51578. as of q4 2014, thiazinamium metilsulfate remains us fdas preferred term for this commodity. thiazinamium metilsulfate bears us nlm identifiers umls id c2825477 and nci concept code c81151. smiles: cc(cn1c2ccccc2sc3c1cccc3)[n+](c)(c)c.cos(=o)(=o)[o-].. "
"antihistamine or h1 blocker propylamines. antihistamine or h1 blocker drugs made from n-propylamine, an amine, c3h9n.. tolpropamine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular structure c18h23n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 1p6c450yet chemically known as benzenepropanamine, n,n,4-trimethyl-.gamma.-phenyl-, hydrochloride (1:1), but more commonly known as tolpropamine hydrochloride, which bears us nih compound identifier 102987. european medicines agency schedules tolpropamine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04913mig. most nations, for tariff and trade purposes, schedule tolpropamine hydrochloride under hs 29214980 and sitc 51454. as of q4 2014, tolpropamine hydrochloride remains us fdas preferred term for this commodity. tolpropamine hydrochloride bears us nlm identifiers umls id c0951394 and nci concept code c97705. smiles: cc1ccc(cc1)c(ccn(c)c)c2ccccc2.cl.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. . "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. chlorphenamine or chlorpheniramine or dexchlorpheniramine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h19cln2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3u6io1965u, chemically known as 3-(p-chlorophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine but generally known as chlorphenamine, which bears us nih compound identifier 2725. european medicines agency schedules chlorphenamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06201mig. the term chlorphenamine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules chlorphenamine in its anatomical therapeutic chemical (atc) classification. chlorphenamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: clc1ccc(c(ccn(c)c)c2ncccc2)cc1.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. acrivastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c22h24n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a20f9xai7w, chemically known as 2-propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (e,e)- but generally known as acrivastine, which bears us nih compound identifier 5284514. european medicines agency schedules acrivastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05252mig. the term acrivastine is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules acrivastine in its anatomical therapeutic chemical (atc) classification. acrivastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acrivastine under hs 29333999 and sitc 51574. as of q4 2014, acrivastine remains the us fda preferred term for this commodity. acrivastine bears us nlm identifiers umls id c0054340 and nci concept code c47383. smiles: oc(=o)/c=c/c1nc(c(=c\\cn2cccc2)\\c2ccc(cc2)c)ccc1.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. betahistine. this classification denotes a vasodilating agent with the molecular formula c8h12n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x32kk4201d, chemically known as 2-pyridineethanamine, n-methyl- but generally known as betahistine, which bears us nih compound identifier 2366. betahistine most often comes in base, dihydrochloride, hydrochloride, and mesylate forms. european medicines agency schedules betahistine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05794mig. the term betahistine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules betahistine in its anatomical therapeutic chemical (atc) classification. betahistine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule betahistine under hs 29333999 and sitc 51574. as of q4 2014, betahistine remains the us fda preferred term for this commodity. betahistine bears us nlm identifiers umls id c0005301 and nci concept code c83554. smiles: n(ccc1ncccc1)c.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. brompheniramine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h19brn2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h57g17p2fn, chemically known as 3-(p-bromophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine but generally known as brompheniramine, which bears us nih compound identifier 6834. brompheniramine most often comes in base and maleate forms. european medicines agency schedules brompheniramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05924mig. the term brompheniramine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules brompheniramine in its anatomical therapeutic chemical (atc) classification. brompheniramine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule brompheniramine under hs 29333999 and sitc 51574. as of q4 2014, brompheniramine remains the us fda preferred term for this commodity. brompheniramine bears us nlm identifiers umls id c0006246 and nci concept code c61655. smiles: brc1ccc(c(ccn(c)c)c2ncccc2)cc1.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. carbinoxamine or rotoxamine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h19cln2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 982a7m02h5, chemically known as pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)- but generally known as carbinoxamine, which bears us nih compound identifier 2564. carbinoxamine most often comes in base and maleate forms. european medicines agency schedules carbinoxamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06128mig. the term carbinoxamine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules carbinoxamine in its anatomical therapeutic chemical (atc) classification. carbinoxamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. carbinoxamine or rotoxamine bears us nlm identifiers umls id c0054672 and nci concept code c65286. smiles: clc1ccc(c(occn(c)c)c2ncccc2)cc1.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. mebhydrolin or mebhydroline. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h20n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9suk9b7xvy, chemically known as 5-benzyl-1,3,4,5-tetrahydro-2-methyl-2h-pyrido(4,3-b)indole but generally known as mebhydrolin, which bears us nih compound identifier 22530. european medicines agency schedules mebhydrolin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08664mig. the term mebhydrolin is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules mebhydrolin in its anatomical therapeutic chemical (atc) classification. mebhydrolin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. mebhydrolin or mebhydroline bears us nlm identifiers umls id c0065834 and nci concept code c66059. smiles: cn1ccc2=c(c1)c3=cc=cc=c3n2cc4=cc=cc=c4.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. dexbrompheniramine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h19brn2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 75t64b71rp, chemically known as 3-(4-bromophenyl)-n,n-dimethyl-3-pyridin-2-yl-propan-1-amine but generally known as dexbrompheniramine, which bears us nih compound identifier 16960. european medicines agency schedules dexbrompheniramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07021mig. world health organization schedules dexbrompheniramine in its anatomical therapeutic chemical (atc) classification. dexbrompheniramine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dexbrompheniramine under hs 29333999 and sitc 51574. as of q4 2014, dexbrompheniramine remains the us fda preferred term for this commodity. dexbrompheniramine bears us nlm identifiers umls id c0057605 and nci concept code c61705. smiles: brc1ccc(c(ccn(c)c)c2ncccc2)cc1.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. doxylamine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h22n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 95qb77jkpl, chemically known as pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)- but generally known as doxylamine, which bears us nih compound identifier 3162. european medicines agency schedules doxylamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06394mig. the term doxylamine is an international non-proprietary name. world health organization schedules doxylamine in its anatomical therapeutic chemical (atc) classification. doxylamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule doxylamine under hs 29333999 and sitc 51574. as of q4 2014, doxylamine remains the us fda preferred term for this commodity. doxylamine bears us nlm identifiers umls id c0013092 and nci concept code c61738. smiles: o(c(c1ccccc1)(c1ncccc1)c)ccn(c)c.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. triprolidine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2l8t9s52qm. european medicines agency schedules triprolidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11323mig. triprolidine generally arises in the molecular formula c19h22n2. the term triprolidine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3.) triprolidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule triprolidine under hs 29333999 and sitc 51574. as of q4 2014, triprolidine remains the us fda preferred term for this commodity. triprolidine bears us nlm identifiers umls id c0041098 and nci concept code c61992. smiles: n1(cccc1)c/c=c(/c1ccc(cc1)c)c1ncccc1.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. pemirolast. this classification denotes a mast cell stabilizer with the molecular formula c10h8n6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2c09nv773m, chemically known as 4h-pyrido(1,2-a)pyrimidin-4-one, 9-methyl-3-(1h-tetrazol-5-yl)- but generally known as pemirolast, which bears us nih compound identifier 57697. european medicines agency schedules pemirolast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09656mig. the term pemirolast is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). pemirolast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pemirolast under hs 29335995 and sitc 51576. as of q4 2014, pemirolast remains the us fda preferred term for this commodity. pemirolast bears us nlm identifiers umls id c0053881 and nci concept code c66334. smiles: cc1=cc=cn2c1=nc=c(c2=o)c3=nnn=n3.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. phenindamine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h19n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 772bq8ksst, chemically known as 2,3,4,9-tetrahydro-2-methyl-9-phenyl-lh-indeno(2,1-c)pyridine but generally known as phenindamine, which bears us nih compound identifier 11291. european medicines agency schedules phenindamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09764mig. the term phenindamine is an international non-proprietary name. world health organization schedules phenindamine in its anatomical therapeutic chemical (atc) classification. phenindamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule phenindamine under hs 29339920 and sitc 51577. as of q4 2014, phenindamine remains the us fda preferred term for this commodity. phenindamine bears us nlm identifiers umls id c0070563 and nci concept code c87745. smiles: n1(cc2=c(cc1)c1c(c2c2ccccc2)cccc1)c.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. pheniramine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h20n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 134fm9zz6m, chemically known as 3-phenyl-3-(2-pyridyl)-n,n-dimethylpropylanine but generally known as pheniramine, which bears us nih compound identifier 4761. european medicines agency schedules pheniramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09768mig. the term pheniramine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules pheniramine in its anatomical therapeutic chemical (atc) classification. pheniramine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pheniramine under hs 29333999 and sitc 51574. as of q4 2014, pheniramine remains the us fda preferred term for this commodity. pheniramine bears us nlm identifiers umls id c0031408 and nci concept code c61889. smiles: n(ccc(c1ccccc1)c1ncccc1)(c)c.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. thenyldiamine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c14h19n3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e4u52363je, chemically known as 1,2-ethanediamine, n,n-dimethyl-n-2-pyridinyl-n-(3-thienylmethyl)- but generally known as thenyldiamine, which bears us nih compound identifier 7066. european medicines agency schedules thenyldiamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10962mig. the term thenyldiamine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). thenyldiamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule thenyldiamine under hs 29349990 and sitc 51579. as of q4 2014, thenyldiamine remains the us fda preferred term for this commodity. thenyldiamine bears us nlm identifiers umls id c0076383 and nci concept code c84200. smiles: s1cc(cn(ccn(c)c)c2ncccc2)cc1.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. betahistine dihydrochloride. this classification denotes a vasodilating agent with the molecular formula c8h12n2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 49k58smz7u, chemically known as 2-pyridineethanamine, n-methyl-, dihydrochloride but more generally known as betahistine dihydrochloride, which bears us nih compound identifier 68643. the base compound, betahistine, most often comes in base, dihydrochloride, hydrochloride, and mesylate forms. european medicines agency schedules betahistine dihydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00772mig. most nations, for tariff and trade purposes, schedule betahistine dihydrochloride under hs 29333999. smiles: cnccc1ccccn1.cl.cl.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. betahistine hydrochloride. this classification denotes a vasodilating agent with the molecular formula c8h12n2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 49k58smz7u, chemically known as 2-pyridineethanamine, n-methyl-, dihydrochloride but more generally known as betahistine dihydrochloride, which bears us nih compound identifier 68643. the base compound, betahistine, most often comes in base, dihydrochloride, hydrochloride, and mesylate forms. european medicines agency schedules betahistine dihydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00772mig. most nations, for tariff and trade purposes, schedule betahistine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, betahistine hydrochloride remains us fdas preferred term for this commodity. betahistine hydrochloride bears us nlm identifiers umls id c0282071 and nci concept code c73794. smiles: cnccc1ccccn1.cl.cl.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. betahistine mesilate. this classification denotes a vasodilating agent with the molecular formula c8h12n2.2ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x1l0e3r43y, chemically known as 2-pyridineethanamine, n-methyl-, dimethanesulfonate but more generally known as betahistine mesilate, which bears us nih compound identifier 198334. the base compound, betahistine, most often comes in base, dihydrochloride, hydrochloride, and mesylate forms. european medicines agency schedules betahistine mesilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00773mig. most nations, for tariff and trade purposes, schedule betahistine mesilate under hs 29333999 and sitc 51574. as of q4 2014, betahistine mesilate remains us fdas preferred term for this commodity. smiles: cnccc1ccccn1.cs(=o)(=o)o.cs(=o)(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. brompheniramine maleate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h19brn2.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ixa7c9zn03, chemically known as 3-(p-bromophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine but more generally known as brompheniramine maleate, which bears us nih compound identifier 6834. european medicines agency schedules brompheniramine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00881mig. most nations, for tariff and trade purposes, schedule brompheniramine maleate under hs 29333999 and sitc 51574. as of q4 2014, brompheniramine maleate remains us fdas preferred term for this commodity. brompheniramine maleate bears us nlm identifiers umls id c0012385 and nci concept code c47422. smiles: cn(c)ccc(c1ccc(cc1)br)c2ccccn2.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. brompheniramine tannate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c76h52o46.c16h19brn2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nqd5087v38. european medicines agency schedules brompheniramine tannate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20623. most nations, for tariff and trade purposes, schedule brompheniramine tannate under hs 29333999 and sitc 51574. smiles: as of q4 2014, brompheniramine tannate remains us fdas preferred term for this commodity.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. carbinoxamine maleate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h19cln2o.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 02o55696wh, chemically known as pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)- but more generally known as carbinoxamine maleate, which bears us nih compound identifier 2564. european medicines agency schedules carbinoxamine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01044mig. most nations, for tariff and trade purposes, schedule carbinoxamine maleate under hs 29333999. as of q4 2014, carbinoxamine maleate remains us fdas preferred term for this commodity. carbinoxamine maleate bears us nlm identifiers umls id c0304300 and nci concept code c47432. smiles: cn(c)ccoc(c1ccc(cc1)cl)c2ccccn2.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. chlorphenamine maleate. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v1q0o9oj9z. european medicines agency schedules chlorphenamine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorphenamine maleate generally arises in the molecular formula c16h19cln2.c4h4o4. the term chlorphenamine maleate is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule chlorphenamine maleate under hs 29333999. smiles: cn(c)ccc(c1ccc(cc1)cl)c2ccccn2.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. chlorphenamine tannate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c76h52o46.c16h19cln2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 72jt935ytt. european medicines agency schedules chlorphenamine tannate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01244mig. most nations, for tariff and trade purposes, schedule chlorphenamine tannate under hs 29333999. smiles:.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. chlorpheniramine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h19cln2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5s6vup419v. most nations, for tariff and trade purposes, schedule chlorpheniramine hydrochloride under hs 29333910. as of q4 2014, chlorpheniramine hydrochloride remains us fdas preferred term for this commodity. chlorpheniramine hydrochloride bears us nlm identifiers umls id c2828313 and nci concept code c87465. smiles: cn(c)ccc(c1ccc(cc1)cl)c2ccccn2.cl.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. chlorpheniramine maleate. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v1q0o9oj9z. european medicines agency schedules chlorphenamine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2.c4h4o4. the term chlorpheniramine maleate is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule chlorpheniramine maleate under hs 29333910. as of q4 2014, chlorpheniramine maleate remains us fdas preferred term for this commodity. chlorpheniramine maleate bears us nlm identifiers umls id c0699075 and nci concept code c28925. smiles: cn(c)ccc(c1ccc(cc1)cl)c2ccccn2.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. chlorpheniramine tannate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c76h52o46.c16h19cln2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 72jt935ytt. european medicines agency schedules chlorphenamine tannate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01244mig. most nations, for tariff and trade purposes, schedule chlorpheniramine tannate under hs 29333910. smiles:. as of q4 2014, chlorpheniramine tannate remains us fdas preferred term for this commodity. . chlorpheniramine tannate bears us nlm identifiers umls id c0724552 and nci concept code c97692.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. dexbrompheniramine maleate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h19brn2.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bpa9ut29bs, chemically known as 2-pyridinepropanamine, gamma-(4-bromophenyl)-n,n-dimethyl-, (s)-, (z)-2-butenedioate (1:1) but more generally known as dexbrompheniramine maleate, which bears us nih compound identifier 6433334. european medicines agency schedules dexbrompheniramine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01626mig. most nations, for tariff and trade purposes, schedule dexbrompheniramine maleate under hs 29333999 and sitc 51574. as of q4 2014, dexbrompheniramine maleate remains us fdas preferred term for this commodity. dexbrompheniramine maleate bears us nlm identifiers umls id c0113291 and nci concept code c61706. smiles: cn(c)cc[c@@h](c1ccc(cc1)br)c2ccccn2.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. dexbrompheniramine tannate. this classification denotes the tannate form of a histamine-1 receptor antagonist with the molecular formula c16h19brn2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 75t64b71rp, chemically known as 3-(4-bromophenyl)-n,n-dimethyl-3-pyridin-2-yl-propan-1-amine but more generally known as dexbrompheniramine, which bears us nih compound identifier 16960. european medicines agency schedules dexbrompheniramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07021mig. world health organization schedules dexbrompheniramine in its anatomical therapeutic chemical (atc) classification. dexbrompheniramine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule dexbrompheniramine tannate under hs 29333999. smiles:. as of q4 2014, dexbrompheniramine tannate remains us fdas preferred term for this commodity.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. dexchlorpheniramine maleate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h19cln2.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b10yd955qw, chemically known as 3-(p-chlorophenyl)-3-(2-pyridyl)-n,n-dimethylpropylamine but more generally known as dexchlorpheniramine maleate, which bears us nih compound identifier 2725. european medicines agency schedules dexchlorpheniramine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01628mig. most nations, for tariff and trade purposes, schedule dexchlorpheniramine maleate under hs 29333999. as of q4 2014, dexchlorpheniramine maleate remains us fdas preferred term for this commodity. dexchlorpheniramine maleate bears us nlm identifiers umls id c0137440 and nci concept code c47478. smiles: cn(c)cc[c@@h](c1ccc(cc1)cl)c2ccccn2.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. doxylamine chlorotheophyllinate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h22n2o.c7h7cln4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier poi7xgq1hn, chemically known as 1h-purine-2,6-dione, 8-chloro-3,9-dihydro-1,3-dimethyl-, compd. with n,n-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine (1:1), but more generally known as doxylamine chlorotheophyllinate, which bears us nih compound identifier 31834. european medicines agency schedules doxylamine chlorotheophyllinate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06394mig. most nations, for tariff purposes, schedule doxylamine chlorotheophyllinate under hs 29333999. smiles: cc(c1ccccc1)(c2ccccn2)occn(c)c.cn1c2c(c(=o)n(c1=o)c)[nh]c(n2)cl.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. doxylamine hydrogen succinate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h22n2o.c4h6o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v9bi9b5yi2, chemically known as succinic acid, compd. with 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine (1:1) (8ci) but more generally known as doxylamine hydrogen succinate, which bears us nih compound identifier 11224. european medicines agency schedules doxylamine hydrogen succinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11925mig. most nations, for tariff and trade purposes, schedule doxylamine hydrogen succinate under hs 29333999. smiles: cc(c1ccccc1)(c2ccccn2)occn(c)c.c(cc(=o)o)c(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. doxylamine succinate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h22n2o.c4h6o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v9bi9b5yi2, chemically known as succinic acid, compd. with 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine (1:1) (8ci) but more generally known as doxylamine hydrogen succinate, which bears us nih compound identifier 11224. european medicines agency schedules doxylamine hydrogen succinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11925mig. most nations, for tariff and trade purposes, schedule doxylamine succinate under hs 29333999 and sitc 51574. as of q4 2014, doxylamine succinate remains us fdas preferred term for this commodity. doxylamine succinate bears us nlm identifiers umls id c0058733 and nci concept code c47501. smiles: cc(c1ccccc1)(c2ccccn2)occn(c)c.c(cc(=o)o)c(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. pemirolast potassium. this classification denotes a mast cell stabilizer with the molecular formula c10h7n6o.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 497a17ouue, chemically known as 9-methyl-3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-one, potassium salt but more generally known as pemirolast potassium, which bears us nih compound identifier 57696. european medicines agency schedules pemirolast potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03670mig. most nations, for tariff and trade purposes, schedule pemirolast potassium under hs 29335995 and sitc 51576. as of q4 2014, pemirolast potassium remains us fdas preferred term for this commodity. pemirolast potassium bears us nlm identifiers umls id c0872971 and nci concept code c47654. smiles: cc1cccn2c1ncc(c2=o)c3[n-]nnn3.[k+].. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. phenindamine hydrogen tartrate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h19n.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 28725x3pv8, chemically known as 2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridine tartrate, but more generally known as phenindamine hydrogen tartrate, which bears us nih compound identifier 11290. european medicines agency schedules phenindamine hydrogen tartrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09764mig. most nations, for tariff purposes, schedule phenindamine hydrogen tartrate under hs 29339920. smiles: cn1ccc2=c(c1)c(c3c2cccc3)c4ccccc4.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. phenindamine tartrate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h19n.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 28725x3pv8, chemically known as 2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridine l-(+)-tartrate (1:1) but more generally known as phenindamine tartrate, which bears us nih compound identifier 11290. european medicines agency schedules phenindamine tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03745mig. most nations, for tariff and trade purposes, schedule phenindamine tartrate under hs 29339920 and sitc 51577. as of q4 2014, phenindamine tartrate remains us fdas preferred term for this commodity. phenindamine tartrate bears us nlm identifiers umls id c0724658 and nci concept code c87746. smiles: cn1ccc2=c(c1)c(c3c2cccc3)c4ccccc4.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. pheniramine aminosalicylate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h20n2.c7h7no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0na6q9i2pb, chemically known as benzoic acid, 4-amino-2-hydroxy-, compd. with n,n-dimethyl-.gamma.-phenyl-2-pyridinepropanamine (1:1), but more generally known as pheniramine aminosalicylate, which bears us nih compound identifier 92952. european medicines agency schedules pheniramine aminosalicylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09768mig. most nations, for tariff purposes, schedule pheniramine aminosalicylate under hs 29333999. smiles: cn(c)ccc(c1ccccc1)c2ccccn2.c1cc(c(cc1n)o)c(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. pheniramine hydrochloride. this classification denotes a histamine-1 receptor antagonist c16h20n2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 10p41di6mi, chemically known as n,n-dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine hydrochloride, but more generally known as pheniramine hydrochloride, which bears us nih compound identifier 91402. most nations, for tariff and trade purposes, schedule pheniramine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, pheniramine hydrochloride remains us fdas preferred term for this commodity. smiles: cn(c)ccc(c1ccccc1)c2ccccn2.cl.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. pheniramine hydrogen maleate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h20n2.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nyw905655b, chemically known as n,n-dimethyl-3-phenyl-3-(2-pyridyl)propylamine hydrogen maleate, but more generally known as pheniramine hydrogen maleate, which bears us nih compound identifier 6433160. european medicines agency schedules pheniramine hydrogen maleate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09768mig. most nations, for tariff purposes, schedule pheniramine hydrogen maleate under hs 29333999. smiles: cn(c)ccc(c1ccccc1)c2ccccn2.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. pheniramine maleate. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nyw905655b. european medicines agency schedules pheniramine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03747mig. pheniramine maleate generally arises in the molecular formula c20h24n2o4. the term pheniramine maleate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule pheniramine maleate under hs 29333999 and sitc 51574. as of q4 2014, pheniramine maleate remains us fdas preferred term for this commodity. pheniramine maleate bears us nlm identifiers umls id c0887016 and nci concept code c29358. smiles: cn(c)ccc(c1ccccc1)c2ccccn2.c(=c\\c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. thenyldiamine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c14h19n3s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7zqc1892h9, chemically known as 1,2-ethanediamine, n,n-dimethyl-n-2-pyridinyl-n-(3-thienylmethyl)-, monohydrochloride but more generally known as thenyldiamine hydrochloride, which bears us nih compound identifier 13734. european medicines agency schedules thenyldiamine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15510mig. most nations, for tariff and trade purposes, schedule thenyldiamine hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, thenyldiamine hydrochloride remains us fdas preferred term for this commodity. thenyldiamine hydrochloride bears us nlm identifiers umls id c0771290 and nci concept code c84201. smiles: cn(c)ccn(cc1ccsc1)c2ccccn2.cl.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. triprolidine hydrochloride. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yan7r5l890. european medicines agency schedules triprolidine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04984mig. triprolidine hydrochloride generally arises in the molecular formula c19h22n2.clh. the term triprolidine hydrochloride is a u.s. pharmacopeial convention designation. most nations, for tariff and trade purposes, schedule triprolidine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, triprolidine hydrochloride remains us fdas preferred term for this commodity. triprolidine hydrochloride bears us nlm identifiers umls id c0242525 and nci concept code c61993. smiles: cc1ccc(cc1)/c(=c\\cn2cccc2)/c3ccccn3.o.cl.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. triprolidine hydrochloride anhydrous. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h22n2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ng7a104r3j, chemically known as (e)-2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)pyridine monohydrochloride, but more generally known as triprolidine hydrochloride anhydrous, which bears us nih compound identifier 5702129. european medicines agency schedules triprolidine hydrochloride anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11323mig. most nations, for tariff purposes, schedule triprolidine hydrochloride anhydrous under hs 29333999. smiles: cc1ccc(cc1)/c(=c\\cn2cccc2)/c3ccccn3.cl.. "
"antihistamine or h1 blocker pyridines. antihistamine or h1 blocker drugs made from compounds with a six membered aromatic ring containing nitrogen.. triprolidine hydrochloride monohydrate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h22n2.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yan7r5l890, chemically known as (e)-2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)pyridine monohydrochloride monohydrate, but more generally known as triprolidine hydrochloride monohydrate, which bears us nih compound identifier 6433473. european medicines agency schedules triprolidine hydrochloride monohydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11323mig. most nations, for tariff purposes, schedule triprolidine hydrochloride monohydrate under hs 29333999. smiles: cc1ccc(cc1)/c(=c\\cn2cccc2)/c3ccccn3.o.cl.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. . "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. isocromil. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0l7ar6g18o. european medicines agency schedules isocromil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08315mig. isocromil generally arises in the molecular formula c19h16o5. the term isocromil is an international non-proprietary name or inn. isocromil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule isocromil under hs 29329985 and sitc 51569. as of q4 2014, isocromil remains the us fda preferred term for this commodity. isocromil bears us nlm identifiers umls id c1881276 and nci concept code c65973. smiles: o(c(c)c)c1c(oc(=o)c2cc3c(occc3=o)cc2)cccc1.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. barmastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c27h29n7o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uif43n1hsv, chemically known as 4h-pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-((3-(2-furanylmethyl)-3h-imidazo(4,5-b)pyridin-2-yl)amino)-1-piperidinyl)ethyl)-2-methyl-;(2) 3-(2-(4-((3-furfuryl-3h-imidazo(4,5-b)pyridin-2-yl)amino)piperidino)ethyl)-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-one but generally known as barmastine, which bears us nih compound identifier 71300. european medicines agency schedules barmastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06104mig. the term barmastine is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). barmastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule barmastine under hs 29349990 and sitc 51579. as of q4 2014, barmastine remains the us fda preferred term for this commodity. barmastine bears us nlm identifiers umls id c2346963 and nci concept code c73043. smiles: o=c1n2c(nc(c1ccn1ccc(nc3n(c4ncccc4n3)cc3occc3)cc1)c)cccc2.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. bepiastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h17n3os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 35qk773y96, chemically known as 6-(2-(dimethylamino)ethyl)pyrido(2,3-b)(1,5)benzothiazepin-5(6h)-one but generally known as bepiastine, which bears us nih compound identifier 185456. european medicines agency schedules bepiastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05777mig. the term bepiastine is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). bepiastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bepiastine under hs 29349990 and sitc 51579. as of q4 2014, bepiastine remains the us fda preferred term for this commodity. bepiastine bears us nlm identifiers umls id c2347002 and nci concept code c73044. smiles: s1c2c(n(ccn(c)c)c(=o)c3c1nccc3)cccc2.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. dimetholizine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o6u9w3dmyt. european medicines agency schedules dimetholizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07174mig. dimetholizine generally arises in the molecular formula c15h24n2o2. the term dimetholizine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4.) dimetholizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dimetholizine under hs 29335995 and sitc 51576. as of q4 2014, dimetholizine remains the us fda preferred term for this commodity. dimetholizine bears us nlm identifiers umls id c1880334 and nci concept code c65405. smiles: o(cccn1ccn(cc1)c1c(oc)cccc1)c.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. dorastine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3087nkh40a. european medicines agency schedules dorastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06370mig. dorastine generally arises in the molecular formula c20h22cln3. the term dorastine is an international non-proprietary name or inn. dorastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dorastine under hs 29333999 and sitc 51574. as of q4 2014, dorastine remains the us fda preferred term for this commodity. dorastine bears us nlm identifiers umls id c2699801 and nci concept code c76061. smiles: clc1cc2c3c(n(c2cc1)ccc1ccc(nc1)c)ccn(c3)c.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. eclazolast. this classification denotes a histamine-1 receptor antagonist with the molecular formula c12h12clno4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r5ell4r7vd, chemically known as 2-benzoxazolecarboxylic acid, 5-chloro-, 2-ethoxyethyl ester but generally known as eclazolast, which bears us nih compound identifier 54550. european medicines agency schedules eclazolast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06448mig. the term eclazolast is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). eclazolast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule eclazolast under hs 29349990 and sitc 51579. as of q4 2014, eclazolast remains the us fda preferred term for this commodity. eclazolast bears us nlm identifiers umls id c0073137 and nci concept code c81140. smiles: ccoccoc(=o)c1=nc2=c(o1)c=cc(=c2)cl.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. elbanizine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c26h31n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s39yd087f9, chemically known as 1-(2-((2,6-dimethyl-3-nitro-4-pyridyl)amino)ethyl)-4-(diphenylmethyl)piperazine. but generally known as elbanizine, which bears us nih compound identifier 208913. european medicines agency schedules elbanizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06478mig. the term elbanizine is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). elbanizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule elbanizine under hs 29335995 and sitc 51576. as of q4 2014, elbanizine remains the us fda preferred term for this commodity. elbanizine bears us nlm identifiers umls id c2348394 and nci concept code c73050. smiles: o[n](=o)c1c(nccn2ccn(cc2)c(c2ccccc2)c2ccccc2)cc(nc1c)c.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. etolotifen. this classification denotes a histamine-1 receptor antagonist with the molecular formula c24h29no4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u64hj4ak57, chemically known as 4,9-dihydro-4-(1-(2-(-2(2-hydroxyethoxy)ethoxy)ethyl)-4-piperidylidene)-10h-ben-zo(4,5)cyclohepta(1,2-b)thiophen-10-one. but generally known as etolotifen, which bears us nih compound identifier 208944. european medicines agency schedules etolotifen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07328mig. the term etolotifen is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). etolotifen is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule etolotifen under hs 29349990 and sitc 51579. as of q4 2014, etolotifen remains the us fda preferred term for this commodity. etolotifen bears us nlm identifiers umls id c1880587 and nci concept code c65593. smiles: s1c2c(c(=c3\\ccn(cc3)ccoccocco)\\c3c(cc2=o)cccc3)cc1.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. flotrenizine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a4jo90697g. european medicines agency schedules flotrenizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07656mig. flotrenizine generally arises in the molecular formula c31h38f2n2o. the term flotrenizine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23.) flotrenizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flotrenizine under hs 29335995 and sitc 51576. as of q4 2014, flotrenizine remains the us fda preferred term for this commodity. flotrenizine bears us nlm identifiers umls id c1880795 and nci concept code c65699. smiles: fc1ccc(c(n2ccn(cc2)cccc(o)c2ccc(c(c)(c)c)cc2)c2ccc(f)cc2)cc1.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. texacromil. this classification denotes a mast cell stabilizer, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2b562k7k56. european medicines agency schedules texacromil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10957mig. texacromil generally arises in the molecular formula c14h14o6s. the term texacromil is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28.) texacromil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule texacromil under hs 29329985 and sitc 51569. as of q4 2014, texacromil remains the us fda preferred term for this commodity. texacromil bears us nlm identifiers umls id c2699924 and nci concept code c76765. smiles: s(cc(o)coc1c2c(oc(cc2=o)c(=o)o)ccc1)c.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. trenizine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1wpq720nck. european medicines agency schedules trenizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11234mig. trenizine generally arises in the molecular formula c31h40n2o. the term trenizine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23.) trenizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trenizine under hs 29335995 and sitc 51576. as of q4 2014, trenizine remains the us fda preferred term for this commodity. trenizine bears us nlm identifiers umls id c1883389 and nci concept code c66622. smiles: oc(cccn1ccn(cc1)c(c1ccccc1)c1ccccc1)c1ccc(c(c)(c)c)cc1.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. dimetholizine phosphate. this classification denotes a histamine-1 receptor antagonist c15h24n2o2.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8vnu0od47w, chemically known as piperazine, 1-(2-methoxyphenyl)-4-(3-methoxypropyl)-, phosphate, but more generally known as dimetholizine phosphate, which bears us nih compound identifier 71586971. most nations, for tariff and trade purposes, schedule dimetholizine phosphate under hs 29335995 and sitc 51576. as of q4 2014, dimetholizine phosphate remains us fdas preferred term for this commodity. smiles: cocccn1ccn(cc1)c2ccccc2oc.op(=o)(o)o.. "
"antihistamine or h1 blockers, synthesized. this classification denotes antihistamine or h1 blockers composed of multiple constituents, with no dominant constituent.. dorastine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c20h22cln3.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0m52541m8x. the term dorastine hydrochloride is a united states adopted name designation. most nations, for tariff and trade purposes, schedule dorastine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, dorastine hydrochloride remains us fdas preferred term for this commodity. dorastine hydrochloride bears us nlm identifiers umls id c2699802 and nci concept code c76062. smiles: cc1ccc(cn1)ccn2c3ccc(cc3c4c2ccn(c4)c)cl.cl.cl.. "
"antihistamine or h1 blocker quinolines. antihistamine or h1 blocker drugs made from compounds consisting of a catabolite of tryptophan.. . "
"antihistamine or h1 blocker quinolines. antihistamine or h1 blocker drugs made from compounds consisting of a catabolite of tryptophan.. minocromil. this classification denotes a histamine-1 receptor antagonist with the molecular formula c18h16n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f37a9vky5q, chemically known as 6-(methylamino)-4-oxo-10-propyl-4h-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid but generally known as minocromil, which bears us nih compound identifier 71448. european medicines agency schedules minocromil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08979mig. the term minocromil is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). minocromil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule minocromil under hs 29349990 and sitc 51579. as of q4 2014, minocromil remains the us fda preferred term for this commodity. minocromil bears us nlm identifiers umls id c0066572 and nci concept code c66162. smiles: o1c2c(ccc)c3nc(cc(nc)c3cc2c(=o)cc1c(=o)o)c(=o)o.. "
"antihistamine or h1 blocker quinolines. antihistamine or h1 blocker drugs made from compounds consisting of a catabolite of tryptophan.. repirinast. this classification denotes a histamine-1 receptor antagonist with the molecular formula c20h21no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4k8ka8b61g, chemically known as 4h-pyrano(3,2-c)quinoline-2-carboxylic acid, 5,6-dihydro-7,8-dimethyl-4,5-dioxo-, isopentyl ester but generally known as repirinast, which bears us nih compound identifier 5050. european medicines agency schedules repirinast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10281mig. the term repirinast is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). repirinast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule repirinast under hs 29349990 and sitc 51579. as of q4 2014, repirinast remains the us fda preferred term for this commodity. repirinast bears us nlm identifiers umls id c0073071 and nci concept code c73053. smiles: o1c2c3c([nh]c(=o)c2c(=o)cc1c(=o)occc(c)c)c(c(cc3)c)c.. "
"antihistamine or h1 blocker quinolizines and sulfonamides and thiazines and thiazoles and thiophenes. this classification denotes antihistamine or h1 blocker drugs made from or based in part on quinolizines, sulfonamides, thiazines, thiazoles, or thiophenes. . "
"antihistamine or h1 blocker quinolizines and sulfonamides and thiazines and thiazoles and thiophenes. this classification denotes antihistamine or h1 blocker drugs made from or based in part on quinolizines, sulfonamides, thiazines, thiazoles, or thiophenes. quinotolast. this classification denotes a histamine-1 receptor antagonist with the molecular formula c17h12n6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier suc3551a8u, chemically known as 4h-quinolizine-3-carboxamide, 4-oxo-1-phenoxy-n-1h-tetrazol-5-yl but generally known as quinotolast, which bears us nih compound identifier 65871. european medicines agency schedules quinotolast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10220mig. the term quinotolast is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). quinotolast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule quinotolast under hs 29337900 and sitc 51561. as of q4 2014, quinotolast remains the us fda preferred term for this commodity. quinotolast bears us nlm identifiers umls id c0210064 and nci concept code c73052. smiles: o(c1c2n(c(=o)c(c1)c(=o)nc1n[nh]nn1)cccc2)c1ccccc1.. "
"antihistamine or h1 blocker quinolizines and sulfonamides and thiazines and thiazoles and thiophenes. this classification denotes antihistamine or h1 blocker drugs made from or based in part on quinolizines, sulfonamides, thiazines, thiazoles, or thiophenes. bosentan. this classification denotes an endothelin receptor antagonist with the molecular formula c27h29n5o6s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q326023r30, chemically known as 4-(1,1-dimethylethyl)-n-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2-bipyrimidin)-4-yl)benzenesulfornamide but generally known as bosentan, which bears us nih compound identifier 104865. bosentan most often comes in basic and hydrate forms. european medicines agency schedules bosentan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05877mig. world health organization schedules bosentan in its anatomical therapeutic chemical (atc) classification. bosentan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bosentan under hs 29350090 and sitc 51580. as of q4 2014, bosentan remains the us fda preferred term for this commodity. bosentan bears us nlm identifiers umls id c0252643 and nci concept code c47417. smiles: s(=o)(=o)(nc1nc(nc(occo)c1oc1c(oc)cccc1)c1ncccn1)c1ccc(c(c)(c)c)cc1.. "
"antihistamine or h1 blocker quinolizines and sulfonamides and thiazines and thiazoles and thiophenes. this classification denotes antihistamine or h1 blocker drugs made from or based in part on quinolizines, sulfonamides, thiazines, thiazoles, or thiophenes. isothipendyl. this classification denotes a histamine antagonist with the molecular formula c16h19n3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wvz7k9p0jy, chemically known as 10h-pyrido(3,2-b)(1,4)benzothiazine-10-ethanamine, n,n,alpha-trimethyl- but generally known as isothipendyl, which bears us nih compound identifier 3781. european medicines agency schedules isothipendyl in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08339mig. world health organization schedules isothipendyl in its anatomical therapeutic chemical (atc) classification. isothipendyl is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule isothipendyl under hs 29349990 and sitc 51579. as of q4 2014, isothipendyl remains the us fda preferred term for this commodity. smiles: s1c2c(n(cc(n(c)c)c)c3ncccc13)cccc2.. "
"antihistamine or h1 blocker quinolizines and sulfonamides and thiazines and thiazoles and thiophenes. this classification denotes antihistamine or h1 blocker drugs made from or based in part on quinolizines, sulfonamides, thiazines, thiazoles, or thiophenes. ketotifen. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h19nos, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x49220t18g, chemically known as 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-10h-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one but generally known as ketotifen, which bears us nih compound identifier 3827. european medicines agency schedules ketotifen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08377mig. the term ketotifen is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). world health organization schedules ketotifen in its anatomical therapeutic chemical (atc) classification. ketotifen is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ketotifen under hs 29349990 and sitc 51579. as of q4 2014, ketotifen remains the us fda preferred term for this commodity. ketotifen bears us nlm identifiers umls id c0022642 and nci concept code c61799. smiles: s1c2c(c(=c3\\ccn(cc3)c)/c3c(cc2=o)cccc3)cc1.. "
"antihistamine or h1 blocker quinolizines and sulfonamides and thiazines and thiazoles and thiophenes. this classification denotes antihistamine or h1 blocker drugs made from or based in part on quinolizines, sulfonamides, thiazines, thiazoles, or thiophenes. zolamine. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nxb79tb0n2. european medicines agency schedules zolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00173mig. zolamine generally arises in the molecular formula c15h21n3os. the term zolamine is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8.) zolamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zolamine under hs 29341000 and sitc 51579. as of q4 2014, zolamine remains the us fda preferred term for this commodity. zolamine bears us nlm identifiers umls id c0301395 and nci concept code c81148. smiles: s1c(n(ccn(c)c)cc2ccc(oc)cc2)ncc1.. "
"antihistamine or h1 blocker quinolizines and sulfonamides and thiazines and thiazoles and thiophenes. this classification denotes antihistamine or h1 blocker drugs made from or based in part on quinolizines, sulfonamides, thiazines, thiazoles, or thiophenes. bosentan hydrate. this classification denotes an endothelin receptor antagonist with the molecular formula c27h29n5o6s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q326023r30, chemically known as benzenesulfonamide, 4-(1,1-dimethylethyl)-n-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2,2bipyrimidin)-4-yl)-, monohydrate, but more generally known as bosentan hydrate, which bears us nih compound identifier 185462. european medicines agency schedules bosentan hydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05877mig. most nations, for tariff purposes, schedule bosentan hydrate under hs 29350090. smiles: cc(c)(c)c1ccc(cc1)s(=o)(=o)nc2c(c(nc(n2)c3ncccn3)occo)oc4ccccc4oc.o.. "
"antihistamine or h1 blocker quinolizines and sulfonamides and thiazines and thiazoles and thiophenes. this classification denotes antihistamine or h1 blocker drugs made from or based in part on quinolizines, sulfonamides, thiazines, thiazoles, or thiophenes. bosentan monohydrate. this classification denotes an endothelin receptor antagonist with the molecular formula c27h29n5o6s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q326023r30, chemically known as 4-(1,1-dimethylethyl)-n-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2-bipyrimidin)-4-yl)benzenesulfornamide but more generally known as bosentan, which bears us nih compound identifier 104865. bosentan most often comes in basic and hydrate forms. european medicines agency schedules bosentan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05877mig. world health organization schedules bosentan in its anatomical therapeutic chemical (atc) classification. bosentan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule bosentan monohydrate under hs 29350090 and sitc 51580. smiles: cc(c)(c)c1ccc(cc1)s(=o)(=o)nc2c(c(nc(n2)c3ncccn3)occo)oc4ccccc4oc.o.. "
"antihistamine or h1 blocker quinolizines and sulfonamides and thiazines and thiazoles and thiophenes. this classification denotes antihistamine or h1 blocker drugs made from or based in part on quinolizines, sulfonamides, thiazines, thiazoles, or thiophenes. isothipendyl hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h19n3s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 953ap1lbv8, chemically known as 10h-pyrido(3,2-b)(1,4)benzothiazine-10-ethanamine, n,n,alpha-trimethyl- but more generally known as isothipendyl hydrochloride, which bears us nih compound identifier 3781. european medicines agency schedules isothipendyl hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02807mig. most nations, for tariff and trade purposes, schedule isothipendyl hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, isothipendyl hydrochloride remains us fdas preferred term for this commodity. isothipendyl hydrochloride bears us nlm identifiers umls id c2079449 and nci concept code c76063. smiles: cc(cn1c2ccccc2sc3c1nccc3)n(c)c.cl.. "
"antihistamine or h1 blocker quinolizines and sulfonamides and thiazines and thiazoles and thiophenes. this classification denotes antihistamine or h1 blocker drugs made from or based in part on quinolizines, sulfonamides, thiazines, thiazoles, or thiophenes. ketotifen fumarate. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h19nos.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hbd503woro, chemically known as 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-10h-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one but more generally known as ketotifen fumarate, which bears us nih compound identifier 3827. european medicines agency schedules ketotifen fumarate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02836mig. most nations, for tariff and trade purposes, schedule ketotifen fumarate under hs 29349990 and sitc 51579. as of q4 2014, ketotifen fumarate remains us fdas preferred term for this commodity. ketotifen fumarate bears us nlm identifiers umls id c0043443 and nci concept code c47579. smiles: cn1ccc(=c2c3ccccc3cc(=o)c4c2ccs4)cc1.c(=c/c(=o)o)\\c(=o)o.. "
"antihistamine or h1 blocker quinolizines and sulfonamides and thiazines and thiazoles and thiophenes. this classification denotes antihistamine or h1 blocker drugs made from or based in part on quinolizines, sulfonamides, thiazines, thiazoles, or thiophenes. zolamine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c15h21n3os.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c2b9cf1640, chemically known as 1,2-ethanediamine, n-((4-methoxyphenyl)methyl)-n,n-dimethyl-n-2-thiazolyl-, monohydrochloride but more generally known as zolamine hydrochloride, which bears us nih compound identifier 14386. most nations, for tariff and trade purposes, schedule zolamine hydrochloride under hs 29341000 and sitc 51579. as of q4 2014, zolamine hydrochloride remains us fdas preferred term for this commodity. zolamine hydrochloride bears us nlm identifiers umls id c2825476 and nci concept code c81149. smiles: cn(c)ccn(cc1ccc(cc1)oc)c2nccs2.cl.. "
"antihistamine or h1 blocker terfenadine/analogs and derivatives. antihistamine or h1 blocker drugs made from a family of hexahydropyridines.. . "
"antihistamine or h1 blocker terfenadine/analogs and derivatives. antihistamine or h1 blocker drugs made from a family of hexahydropyridines.. fexofenadine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c32h39no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e6582loh6v, chemically known as 4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid but generally known as fexofenadine, which bears us nih compound identifier 3348. european medicines agency schedules fexofenadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13883mig. the term fexofenadine is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). world health organization schedules fexofenadine in its anatomical therapeutic chemical (atc) classification. fexofenadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fexofenadine under hs 29333999 and sitc 51574. as of q4 2014, fexofenadine remains the us fda preferred term for this commodity. fexofenadine bears us nlm identifiers umls id c0296800 and nci concept code c61764. smiles: oc(c1ccn(cc1)cccc(o)c1ccc(c(c)(c)c(=o)o)cc1)(c1ccccc1)c1ccccc1.. "
"antihistamine or h1 blocker terfenadine/analogs and derivatives. antihistamine or h1 blocker drugs made from a family of hexahydropyridines.. fexofenadine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c32h39no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2s068b75zu, chemically known as 3,5-pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester but generally known as fexofenadine hydrochloride, which bears us nih compound identifier 3333. european medicines agency schedules fexofenadine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13884mig. most nations schedule fexofenadine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, fexofenadine hydrochloride remains the us fda preferred term for this commodity. fexofenadine hydrochloride bears us nlm identifiers umls id c0771752 and nci concept code c29050. smiles: cc(c)(c1=cc=c(c=c1)c(cccn2ccc(cc2)c(c3=cc=cc=c3)(c4=cc=cc=c4)o)o)c(=o)o.cl.. "
"antihistamine or h1 blocker tetrazoles. antihistamine or h1 blocker drugs made from a 5-member ring of four nitrogen atom and one carbon atom, based on cn4h2.. . "
"antihistamine or h1 blocker tetrazoles. antihistamine or h1 blocker drugs made from a 5-member ring of four nitrogen atom and one carbon atom, based on cn4h2.. eflumast. this classification denotes a histamine-1 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3cig2v70ub. european medicines agency schedules eflumast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06470mig. eflumast generally arises in the molecular formula c10h8fn5o3. the term eflumast is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30.) eflumast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule eflumast under hs 29339990 and sitc 51577. as of q4 2014, eflumast remains the us fda preferred term for this commodity. eflumast bears us nlm identifiers umls id c0654074 and nci concept code c73049. smiles: cc(=o)c1=cc(=cc(=nc(=o)c2=nnnn2)c1=o)f.. "
"antihistamine or h1 blocker tetrazoles. antihistamine or h1 blocker drugs made from a 5-member ring of four nitrogen atom and one carbon atom, based on cn4h2.. tazanolast. this classification denotes a mast cell stabilizer with the molecular formula c13h15n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t0248823h1, chemically known as acetic acid, oxo((3-(1h-tetrazol-5-yl)phenyl)amino)-, butyl ester but generally known as tazanolast, which bears us nih compound identifier 5380. european medicines agency schedules tazanolast in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10843mig. the term tazanolast is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). tazanolast is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tazanolast under hs 29339990 and sitc 51577. as of q4 2014, tazanolast remains the us fda preferred term for this commodity. tazanolast bears us nlm identifiers umls id c0539675 and nci concept code c76764. smiles: o(cccc)c(=o)c(=o)nc1cc(ccc1)c1n[nh]nn1.. "
"antihistamine or h1 blocker pyrimidines. antihistamine or h1 blocker drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. . "
"antihistamine or h1 blocker pyrimidines. antihistamine or h1 blocker drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. donetidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c20h25n5o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e9730rxs4h, chemically known as 5-((1,2-dihydro-2-oxo-4-pyridyl)methyl)-2-((2-((5-((dimethylamino)methyl)furfuryl)thio)ethyl)amino)-4(1h)-pyrimidinone but generally known as donetidine, which bears us nih compound identifier 57484. european medicines agency schedules donetidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06363mig. the term donetidine is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). donetidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule donetidine under hs 29349990 and sitc 51579. as of q4 2014, donetidine remains the us fda preferred term for this commodity. donetidine bears us nlm identifiers umls id c0074641 and nci concept code c77439. smiles: s(cc1oc(cn(c)c)cc1)ccnc1[nh]c(=o)c(cc2c(=o)[nh]ccc2)cn1.. "
"antihistamine or h1 blocker pyrimidines. antihistamine or h1 blocker drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. temelastine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h24brn5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bf6igi53xh, chemically known as 4(1h)-pyrimidinone, 2-((4-(5-bromo-3-methyl-2-pyridinyl)butyl)amino)-5-((6-methyl-3-pyridinyl)methyl)- but generally known as temelastine, which bears us nih compound identifier 55482. european medicines agency schedules temelastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10882mig. the term temelastine is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). temelastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule temelastine under hs 29335995 and sitc 51576. as of q4 2014, temelastine remains the us fda preferred term for this commodity. temelastine bears us nlm identifiers umls id c0076078 and nci concept code c73058. smiles: brc1cc(c(nc1)ccccnc1[nh]c(=o)c(cc2ccc(nc2)c)cn1)c.. "
"antihistamine or h1 blocker pyrimidines. antihistamine or h1 blocker drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. thonzylamine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h22n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r79646h5z8, chemically known as pyrimidine, 2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)- but generally known as thonzylamine, which bears us nih compound identifier 5457. european medicines agency schedules thonzylamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10988mig. the term thonzylamine is an international non-proprietary name. world health organization schedules thonzylamine in its anatomical therapeutic chemical (atc) classification. thonzylamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule thonzylamine under hs 29335995 and sitc 51576. as of q4 2014, thonzylamine remains the us fda preferred term for this commodity. thonzylamine bears us nlm identifiers umls id c0175162 and nci concept code c84204. smiles: o(c1ccc(cn(ccn(c)c)c2ncccn2)cc1)c.. "
"antihistamine or h1 blocker pyrimidines. antihistamine or h1 blocker drugs made from a family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms.. thonzylamine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c16h22n4o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6k9ykd48y4, chemically known as 2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)pyrimidine hydrochloride, but more generally known as thonzylamine hydrochloride, which bears us nih compound identifier 6136. european medicines agency schedules thonzylamine hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10988mig. most nations, for tariff purposes, schedule thonzylamine hydrochloride under hs 29335995. thonzylamine hydrochloride bears us nlm identifiers umls id c1563662 and nci concept code c84205. smiles: cn(c)ccn(cc1ccc(cc1)oc)c2ncccn2.cl.. "
"antihistamine or h1 blocker tropanes. this classification denotes antihistaminea or h1 blockers based on n-methyl-8-azabicyclo[3.2.1]octanes best known for the ones found in plants, sometimes called azabicyclo(3.2.1)octanes, and from whence many alkaloids come.. . "
"antihistamine or h1 blocker tropanes. this classification denotes antihistaminea or h1 blockers based on n-methyl-8-azabicyclo[3.2.1]octanes best known for the ones found in plants, sometimes called azabicyclo(3.2.1)octanes, and from whence many alkaloids come.. hypostamine or tritoqualine. this classification denotes a cholagogue, choleretic, histamine h1 antagonist, and phthalic anhydride with the molecular formula c26h32n2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f4mw5166yh, chemically known as 4,5,6-triethoxy-7-amino-3-(8-methoxy-2-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydro-1-isochinolinyl)phthalid but generally known as tritoqualine, which bears us nih compound identifier 72145. european medicines agency schedules tritoqualine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11326mig. world health organization schedules tritoqualine in its anatomical therapeutic chemical (atc) classification. tritoqualine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. hypostamine or tritoqualine bears us nlm identifiers umls id c0077316 and nci concept code c97409. smiles: o1c(c2n(ccc3c2c(oc)c2ococ2c3)c)c2c(c1=o)c(n)c(occ)c(occ)c2occ.. "
"antihistamine or h1 blocker tropanes. this classification denotes antihistaminea or h1 blockers based on n-methyl-8-azabicyclo[3.2.1]octanes best known for the ones found in plants, sometimes called azabicyclo(3.2.1)octanes, and from whence many alkaloids come.. flutropium. this classification denotes a mast cell stabilizer with the molecular formula c24h29fno3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ta73fx29ii, chemically known as [(1r,5r)-8-(2-fluoroethyl)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl]2-hydroxy-2,2-diphenylacetate but generally known as flutropium, which bears us nih compound identifier 71962. european medicines agency schedules flutropium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02242mig. the term flutropium is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). as of q4 2014, flutropium remains the us fda preferred term for this commodity. flutropium bears us nlm identifiers umls id c0873172 and nci concept code c87639. smiles: c[n+]1(c2ccc1cc(c2)oc(=o)c(c3=cc=cc=c3)(c4=cc=cc=c4)o)ccf.. "
"antihistamine or h1 blocker tropanes. this classification denotes antihistaminea or h1 blockers based on n-methyl-8-azabicyclo[3.2.1]octanes best known for the ones found in plants, sometimes called azabicyclo(3.2.1)octanes, and from whence many alkaloids come.. flutropium bromide. this classification denotes a mast cell stabilizer with the molecular formula c24h29fno3.br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k3v6hb0m57, chemically known as 1-alpha-h,5-alpha-h-tropanium, 8-(2-fluoroethyl)-3-alpha-hydroxy-, bromide, benzilate, (8r)- but more generally known as flutropium bromide, which bears us nih compound identifier 71962. european medicines agency schedules flutropium bromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07767mig. the term flutropium bromide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 38, no. 6, 1984, list 24). most nations, for tariff and trade purposes, schedule flutropium bromide under hs 29399900 and sitc 54149. as of q4 2014, flutropium bromide remains us fdas preferred term for this commodity. flutropium bromide bears us nlm identifiers umls id c0117999 and nci concept code c80960. smiles: c[n+]1([c@@h]2cc[c@@h]1cc(c2)oc(=o)c(c3ccccc3)(c4ccccc4)o)ccf.[br-].. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. . "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. acetaminophen/dextromethorphan/phenylephrine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re506. this va drug class (re506) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an alpha-adrenergic agonist with the molecular formula c9h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1ws297w6mv, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears u.s. national institutes of health compound identifier 6041. the european medicines agency schedules phenylephrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09788mig. the term phenylephrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). the world health organization schedules phenylephrine in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is the fifth component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c17h23n3o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier hpe317o9tl, chemically known as n,n-dimethyl-n-(p-methoxybenzyl)-n-(2-pyridyl)ethylenediamine but more generally known as pyrilamine, which bears u.s. national institutes of health compound identifier 4992.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. acetaminophen/chlorpheniramine/dextromethorphan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re509. this va drug class (re509) classifies this compound as belonging to the group antihistamine/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component os this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (as maleate) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2. the term chlorpheniramine is a european pharmacopoeia designation. the third component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. carbinoxamine/gauifenesin/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. carbinoxamine/methscopolamine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. carbinoxamine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. cetirizine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/citric acid/guaifenesin/phenylpropanolamine/sodium citrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/dextromethorphan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re507. this va drug class (re507) classifies this compound as belonging to the group antihistamine/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/dextromethorphan/glycerol, iodinated. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re508. this va drug class (re508) classifies this compound as belonging to the group antihistamine/antitussive/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/dextromethorphan/guaifenesin/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re504. this va drug class (re504) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. brompheniramine/guaifenesin/menthol/phenylephrine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. acrivastine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. ammonium chloride/chlorpheniramine/dextromethorphan/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re504. this va drug class (re504) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. ascorbic acid/chlorpheniramine/phenylpropanolamine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. aspirin/chlorpheniramine/dextromethorphan/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re506. this va drug class (re506) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/analgesic.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. azatadine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. belladonna/chlorpheniramine/pheniramine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. bromphenhiramine/dextromethorphan/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. brompheniramine/dextromethorphan/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. brompheniramine/dextromethorphan/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. carbetapentane/phenylephrine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. brompheniramine/guaifenesin/phenylephrine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. brompheniramine/guaifenesin/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. brompheniramine/phenylephrine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. brompheniramine/phenylephrine/phenyltoloxamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. brompheniramine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. brompheniramine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. carbetapentane/chlorpheniramine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. carbetapentane/chlorpheniramine/ephedrine/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. carbetapentane/phenylephrine/phenylpropanolamine/potassium. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re504. this va drug class (re504) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. carbinoxamine/dextromethorphan/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/guaifenesin/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/dextromethorphan/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/dextromethorphan/phenylephrine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/dextromethorphan/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/dextromethorphan/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/ephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/ephedrine/guaifenesin/hydriodic acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/guaifenesin/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/guaifenesin/phenylephrine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/guaifenesin/phenylephrine/phenylpropanolamine/p. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/phenylpropanolamine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/guaifenesin/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/phenylephrine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/phenylephrine/phenylpropanolamine/phenyltoloxamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/phenylephrine/phenylpropanolamine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/phenylephrine/phenyltoloxamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/phenylephrine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. dexbrompheniramine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/phenylpropanolamine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. citric/dextromethorphan/ipecac/potassium/promethazine/sodium citrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re302. this va drug class (re302) classifies this compound as belonging to the group non-opioid-containing antitussives/expectorants.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. citric/ipecac/phenylephrine/potassium/promethazine/sodium citrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. citric/ipecac/potassium/promethazine/sodium citrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. clemastine/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. desloratadine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. diphenhydramine/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. dexchlorpheniramine/dextromethorphan/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. dexchlorpheniramine/guaifenesin/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. dextromethorphan/doxylamine/guaifenesin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re508. this va drug class (re508) classifies this compound as belonging to the group antihistamine/antitussive/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. dextromethorphan/guaifenesin/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. dextromethorphan/ipecac/potassium guaiacolsulfonate/promethazine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re508. this va drug class (re508) classifies this compound as belonging to the group antihistamine/antitussive/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. dextromethorphan/phenylephrine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re502. this va drug class (re502) classifies this compound as belonging to the group antihistamine/decongestant/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. dextromethorphan/potassium guaiacolsulfonate/promethazine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re508. this va drug class (re508) classifies this compound as belonging to the group antihistamine/antitussive/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. dextromethorphan/promethazine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re507. this va drug class (re507) classifies this compound as belonging to the group antihistamine/antitussive.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. pheniramine/phenylpropanolamine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. diphenhydramine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. fexofenadine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. ipecac/phenylephrine/potassium guaiacolsulfonate/promethazine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. loratadine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. menthol/pheniramine/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. pheniramine/phenylpropanolamine/phenyltoloxamine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. pheniramine/phenyltoloxamine/pyrilamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ah109. this va drug class (ah109) classifies this compound as belonging to the group antihistamines, other.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. phenylephrine/potassium guaiacolsulfonate/promethazine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. phenylephrine/promethazine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. promethazine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. pseudoephedrine/terfenadine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. pseudoephedrine/triprolidine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re501. this va drug class (re501) classifies this compound as belonging to the group antihistamine/decongestant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. chlorpheniramine/dextromethorphan/guaifenesin/phenylephrine/sodium salicylate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re504. this va drug class (re504) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/expectorant.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re506. this va drug class (re506) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component os this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (as maleate) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2. the term chlorpheniramine is a european pharmacopoeia designation. the third component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is an alpha-adrenergic agonist with the molecular formula c9h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1ws297w6mv, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears u.s. national institutes of health compound identifier 6041. the european medicines agency schedules phenylephrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09788mig. the term phenylephrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). the world health organization schedules phenylephrine in its anatomical therapeutic chemical (atc) classification.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. acetaminophen/chlorpheniramine/dextromethorphan/phenylpropanolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re506. this va drug class (re506) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component os this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (as maleate) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2. the term chlorpheniramine is a european pharmacopoeia designation. the third component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the fourth component of thiss combination drug is an adrenergic agonist with the molecular formula c9h13no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 33ru150wun, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears u.s. national institutes of health compound identifier 4786. the european medicines agency schedules phenylpropanolamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09790mig. the term phenylpropanolamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). the world health organization schedules phenylpropanolamine in its anatomical therapeutic chemical (atc) classification.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class re506. this va drug class (re506) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component os this combination drug is a histamine-1 receptor antagonist, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3u6io1965u. the european medicines agency schedules chlorphenamine (as maleate) in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01243mig. chlorpheniramine maleate generally arises in the molecular formula c16h19cln2. the term chlorpheniramine is a european pharmacopoeia designation. the third component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. acetaminophen/dextromethorphan/diphenhydramine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re506. this va drug class (re506) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is a histamine-1 receptor antagonist and antiemetic agent with the molecular formula c17h21no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 8gts82s83m, chemically known as 2-(diphenylmethoxy)-n,n-dimethylethylamine hydrochloride but more generally known as diphenhydramine, which bears u.s. national institutes of health compound identifier 3100. the european medicines agency schedules diphenhydramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07211mig. the term diphenhydramine is an international non-proprietary name. the world health organization schedules diphenhydramine in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. acetaminophen/dextromethorphan/doxylamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re509. this va drug class (re509) classifies this compound as belonging to the group antihistamine/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c17h22n2o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 95qb77jkpl, chemically known as pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)- but more generally known as doxylamine, which bears u.s. national institutes of health compound identifier 3162. the european medicines agency schedules doxylamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06394mig. the term doxylamine is an international non-proprietary name. the world health organization schedules doxylamine in its anatomical therapeutic chemical (atc) classification.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. acetaminophen/dextromethorphan/doxylamine/ephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re506. this va drug class (re506) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c17h22n2o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 95qb77jkpl, chemically known as pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)- but more generally known as doxylamine, which bears u.s. national institutes of health compound identifier 3162. the european medicines agency schedules doxylamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06394mig. the term doxylamine is an international non-proprietary name. the world health organization schedules doxylamine in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is an adrenergic agent with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier gn83c131xs, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as ephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules ephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13683mig. the world health organization schedules ephedrine in its anatomical therapeutic chemical (atc) classification.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. acetaminophen/dextromethorphan/doxylamine/pseudoephedrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re506. this va drug class (re506) classifies this compound as belonging to the group antihistamine/decongestant/antitussive/analgesic. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is a histamine-1 receptor antagonist with the molecular formula c17h22n2o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 95qb77jkpl, chemically known as pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)- but more generally known as doxylamine, which bears u.s. national institutes of health compound identifier 3162. the european medicines agency schedules doxylamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06394mig. the term doxylamine is an international non-proprietary name. the world health organization schedules doxylamine in its anatomical therapeutic chemical (atc) classification. the fourth component of this combination drug is an alpha-adrenergic agonist with the molecular formula c10h15no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7cuc9ddi9f, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but more generally known as pseudoephedrine, which bears u.s. national institutes of health compound identifier 5032. the european medicines agency schedules pseudoephedrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10157mig. the term pseudoephedrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). the world health organization schedules pseudoephedrine in its anatomical therapeutic chemical (atc) classification.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. acetaminophen/dextromethorphan/phenylephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class re503. this va drug class (re503) classifies this compound as belonging to the group antihistamine/decongestant/expectorant. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears u.s. national institutes of health compound identifier 3008. the european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. the world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an alpha-adrenergic agonist with the molecular formula c9h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 1ws297w6mv, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears u.s. national institutes of health compound identifier 6041. the european medicines agency schedules phenylephrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09788mig. the term phenylephrine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). the world health organization schedules phenylephrine in its anatomical therapeutic chemical (atc) classification.. "
"combination antihistamines, with analgesics, antitussives, decongestants, or expectorants. this classification denotes a) combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence; b) combination drugs containing preparations capable of relieving pain without the loss of consciousness, or of creating a condition of non-pain, hence the term analgesics; c) combination drugs containing preparations that suppress cough, hence the term antitussives; d) containing preparations designed to treat inflammation of the nasal passages, hence the term decongestants; and/or e) combination drugs containing preparations that increase mucous excretion, hence the term expectorants. typical combination antihistamine, with analgesic, antitussive, decongestant, or expectorant constituents are azatadine, bromphenhiramine, carbetapentane, desloratadine, fexofenadine, loratadine, menthol, phenylephrine, and pseudoephedrine.. ambroxol/dextromethorphan. this classification denotes a combination drug composed of two constituents: a mucolytic and an opioid receptor agonist and opioid, as more fully appears. the first constituent, ambroxol (51162702), is an expectorant and amino-alcohol that bears the molecular formula c13h18br2n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 200168s0cl, chemically known as 4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol but more generally known as ambroxol [eu/esis 242-500-3]; ambroxol comes in forms acefyllinate [0hm1e174tn], base, and hydrochloride [cc995zmv90]. european medicines agency schedules ambroxol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05397mig (base), sub12842mig (acefyllinate), and sub00427mig (hydrochloride). the term ambroxol is an international non-proprietary name or inn. world health organization schedules ambroxol in its anatomical therapeutic chemical (atc) classification (r05cb06) and in its who drug dictionary. ambroxol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ambroxol under hs 29221980 and sitc 51461. us census, for industry purposes, classifies ambroxol under naics 325199. the second component of this combination drug, dextromethorphan (51162626), is an opioid receptor agonist and opioid with the molecular formula c18h25no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 7355x3rots, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears us nih compound identifier 3008. dextromethorphan {51162626} comes in forms base, hydriodide, hydrobromide, hydrobromide anhydrous, hydrochloride, salicylate, and tannate ([086f8zem77], [9d2rti9kyh], [351kfh969d], [b2f298x1aj], [554r584p9k]); it further serves in many other combination drugs with doxylamine, dyphylline, glycerol, guaifenesin, ipecac, phenylephrine, phenylpropanolamine, potassium, promethazine, pseudoephedrine, quinidine, terpin hydrate ({51143708}, {51162018}, {51162401}, {51162408}, {51162409}, {51162410}, {51162411}, {51162412}, {51162510}, {51162511}, {51314363}, {51314364}, {51314365}, {51314366}, {51314367}, {51314368}). european medicines agency schedules dextromethorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07051mig. the term dextromethorphan is an international non-proprietary name. world health organization schedules dextromethorphan in its anatomical therapeutic chemical (atc) classification. dextromethorphan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule dextromethorphan under hs 29334930 and sitc 51575. as of q4 2014, dextromethorphan remains us fdas preferred term for this commodity. dextromethorphan bears us nlm identifiers umls id c0011816 and nci concept code c62022.. "
